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Abstract
Transection of the facial nerve results in morbidity for the patient, which is both physical and
psychological. Neurotrophic factors have been shown to support motor neurones in vitro and
some studies have shown a benefit to nerve regeneration in vivo. The present work established
a model for the electrophysiological assessment of the rat facial nerve and used the rat and the
sheep as animal models for facial nerve repair. In the rat facial nerve, after transection and
repair of the buccal division, there was an increase in the number of regenerated axons with
10 pg of both CNTF and BDNF administered exogenously near the site of nerve repair, over a
period of 14 days (p=0.003). There was no increase in the number of fibres with similar
administration of GDNF and NT 4/5. The administration of these neurotrophic factors failed
to show any other improvement in electrophysiological or morphometric measurements in the
rat nerve. The advantage of increasing the number of fibres after repair is dubious. In the
sheep facial nerve three groups of animals were studied. Group 1 underwent nerve division
and repair, group 2 underwent nerve division, repair and entubulation with a biodegradable
glass tube and group 3 underwent nerve division and repair with administration of
neurotrophic factors. In group 3 exogenous administration of 100 pg of CNTF and 50 pg of
both BDNF and GDNF, over a period of 28 days, failed to show any improvement in
electrophysiological or morphometric measurements. Nerve entubulation also failed to show
any improvement in morphometric measurements but did show an increase in minimum
conduction velocity. The reason for this was not clear and may be a spurious result. This
study provides evidence for the use ofCNTF and BDNF to increase the number of fibres after
facial nerve repair on the rat. The functional advantage of this is uncertain. At present, the use
of these neurotrophic factors cannot be supported in peripheral motor nerve repair.
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Anatomy and pathology of the facial nerve






The facial nerve, the seventh cranial nerve, controls the muscles of facial expression. It is this
nerve that gives us the ability, at least in part, to blink, smile, talk, sing, eat and play a variety
of musical instruments. Loss of function of this nerve, in the human subject, results in
considerable morbidity and a diminished quality of life. Morbidity is most often related to the
inability to close the eye and this can result in keratitis and corneal ulceration. Speech can be
impaired and the failure of the sphincter mechanism of the mouth results in loss of food and
especially fluid while eating and drinking. Perhaps the most dramatic impact of facial
paralysis, however, is the psychological effect on the patient. Sufferers are self-conscious and
this can result in cases of isolation and fear of interaction with others. The cosmetic deformity
of a complete facial paralysis is evident to everyone, even on cursory inspection. The accurate
repair of a physical disruption to the nerve with no or minimal residual deficit is the goal of
surgery when spontaneous resolution will not occur.
Anatomy and pathology of the facial nerve
Situated in the lower third of the pons, the facial motor nucleus contains approximately 7000
neurones. Fibres from the facial nucleus must loop around the adbucens nucleus (forming the
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facial colliculus) before emerging from the brain stem. The nerve has a motor and a sensory
root (the nervus intermedins). The two roots emerge from the caudal border of the pons,
lateral to the recess between the inferior olive and inferior cerebellar peduncle, at the
cerebellopontine angle. The motor root lies medial, and the vestibulocochlear nerve lies lateral,
to the nervus intermedius. The two roots of the facial nerve and the vestibulocochlear nerve
pass anterolateral^ to the internal acoustic meatus. At the lateral end of the meatus the nerve
enters the facial canal (Fallopian canal), lying above the vestibule; it then turns at the
geniculum to produce the genicular ganglion and travels posteriorly through a bony canal on
the medial wall of the middle ear. Here the facial nerve is unique. No other nerve in the body
has such a long course (28-30 mm) in a bony canal. In the middle ear the facial canal lies
behind the processus cochleariformis and tensor tympani tendon. The nerve travels
horizontally above the oval window and the stapes. The facial nerve then turns downwards
forming the second genu, the start of the mastoid segment of the nerve. It then runs vertically
down the anterior wall of the mastoid process to emerge from the stylomastoid foramen. Near
the foramen three branches arise. First, the posterior auricular branch, which ascends in front
of the mastoid process, giving auricular and occipital branches to supply auricular muscles
and the occipital belly of occipitofrontalis respectively. Second, the digastric branch which
supplies the posterior belly of the digastric muscle and third, the stylohyoid branch which
supplies the stylohyoid muscle. The main trunk of the facial nerve emerges from the
stylomastoid foramen to run forwards in the parotid gland, crossing the styloid process,
retromandibular vein and external carotid artery. Within the substance of the parotid gland the
nerve divides into its terminal branches (temporal, zygomatic, buccal, mandibular and
cervical). The temporal branch crosses the zygomatic arch supplying intrinsic muscles on the
lateral surface of the auricle and the anterior and superior auricular muscles. The more
anterior branches supply the frontal belly of occipitofrontalis, orbicularis oculi and
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corrugator. The zygomatic branches cross the zygomatic bone to the lateral canthus,
supplying orbicularis oculi. The buccal branch passes horizontally to a distribution below the
orbit and around the mouth. This branch supplies procerus, the zygomaticus muscles, levator
labii superioris, levator anguli oris, levator labii superioris alaeque nasi, buccinator and
orbicularis oris. The mandibular branch runs forwards below the angle of the mandible,
turning again above the mandible to supply the risorius and muscles of the lower lip and chin.
The cervical branch runs anteroinferiorly to the front of the neck, under platysma, which it
supplies (Gray's Anatomy 1989). Damage to the infra-nuclear facial nerve can happen
anywhere alone its course.
The intracranial portion of the facial nerve can be affected by cerebellopontine angle tumours.
The majority of these are vestibular schwannomas although other tumours include
menigiomas, facial nerve schwannomas and congenital cholesteatomas. Any such pathology
can cause facial paralysis although a more likely cause of facial paralysis is the surgical
treatment of these tumours. The temporal portion of the facial nerve is at risk in fractures,
osteitis and malignant tumours of the temporal bone. In advanced squamous carcinoma of the
middle ear, subtotal petrosectomy may offer potential cure but will usually involve sacrifice of
the facial nerve (Schaitkin & May 1997). Iatrogenous injury to the nerve can arise from
mastoid and middle ear surgery, and this represents the greatest risk to the trunk of the facial
nerve, potentially resulting in a permanent and total palsy. Chronic otitis media (mucosal and
squamosal) can be responsible for paralysis of the nerve as can glomus jugulare and glomus
tympanicum tumours. The extratemporal facial nerve is at risk in parotid surgery and from
malignant parotid, oropharyngeal and nasopharyngeal tumours. Without the protection of the
skull, the extratemporal facial nerve is vulnerable to penetrating trauma of the face. In infants,
the mastoid process is undeveloped and the facial nerve lacks its protection, lying more
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superficial and is thus more prone to injury by obstetric forceps or a mastoid exploration
incision. The mandibular division of the facial nerve is at risk in anterior neck surgery such as
submandibular gland excision for sialectasis or tumour. Thus, with many of the these
disorders, or their treatment, paresis of the muscles supplied by the facial nerve is a potential
outcome. Surgical repair offers, in many cases, the only possible hope for recovery. Yet even
with the advances in microsurgery of the twentieth century, the results of nerve coaptation and
grafting are disappointing. With meticulous technique of the best that microsurgery has to
offer, recovery may be disappointing or even negligible. It is unlikely that further
advancements in surgical technique offer real hope for the damaged peripheral nervous
system. Much effort has thus been concentrated on 'neurotrophic factors' or nerve rescue
agents in the hope that these may raise the plateau on which current surgical practice rests
with respect to nerve coaptation.
Assessment of facial nerve function
The most widely known standard for assessment of facial nerve function and recovery is the
House-Brackmann grading system (House & Brackmann 1985). Some journals require the use
of this system when reporting results. The system is based on a six-point scale with 1 being
normal and VI being total, flaccid paralysis (table 1.1). This system involves making
measurements of the movement of the eyebrow and corner of the mouth and comparing the
results with those on the unaffected side, which assists the categorization of the patient into
one of the six grades.
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Grade Description Characteristics
I Normal Normal function in all areas
II Mild
dysfunction
Gross: slight weakness noticeable on close inspection; may
have very slight synkinesis
At rest: normal symmetry and tone
Motion
Forehead: moderate to good function




Gross: obvious but not disfiguring difference between two
sides; noticeable but not severe synkinesis, contracture, and / or
hemifacial spasm
At rest: normal symmetry and tone
Motion
Forehead: slight to moderate movement
Eye: complete closure with effort




Gross: obvious weakness and / or disfiguring asymmetry




Mouth: asymmetric with maximum effort
V Severe
dysfunction






VI Total paralysis No movement
Table 1.1 House-Brackmann facial nerve grading system.
The above is an invaluable grading system which has helped the consistent reporting of a
patient's facial nerve function over time and helped to standardise reporting of facial nerve
function between patients. This grading system however, still relies on subjectivity on the part
of the physician. Electrophysiological assessment of the facial nerve is a common practice,
indeed the seventh cranial nerve is the most common single nerve assessed by
electrophysiology. This is because Bell's palsy is the most common mono-neuropathy, and
where electrophysiological assessment is an accurate prognostic indicator of recovery.
There are several electrophysiological ways to assess nerve function. The ideal
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electrophysiological test does not exist, and clinically, several tests have been used to assess
the function of the facial nerve:
1. testing of nerve excitability
2. nerve latency
3. electromyography
4. compound muscle action potential
5. maximum stimulation test
6. blink reflex
Nerve excitability testing (NET) uses electrical stimulation of the facial nerve at the
stylomastoid foramen. The NET measures the level of current required to evoke a minimally
visible muscle contraction on one side of the face, comparing this to the opposite side. A
clinically significant side-to-side difference varies between 2.0 and 3.5 mA or more (Alford
1967; Campbell et al. 1962; Grodon & Friedberg 1978), and is an accurate indicator of poor
recovery in Bell's palsy.
Facial nerve latency testing uses similar electrical stimulation of the nerve at the stylomastoid
foramen to NET. Instead of being observed, the muscle response is recorded electrically and
the latency is measured from stimulus to the initial deflection of the motor response. A normal
latency is 4 ms (Dumitru et al 1988). A normal latency would be expected even if only a small
number of fast conducting axons remained. In contrast, if fast conducting axons were
preferentially affected, a prolongation of the latency would be expected. Poor correlation
between normal latencies and recovery has limited the usefulness of this test as a
prognosticator of facial nerve recovery in acute palsies (Blumenthal & May 1986; Esslen
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1977). It has, however, been useful in chronic diseases such as Charcot-Marie-Tooth,
Guillain-Barre syndrome and other peripheral neuropathies (Johnson & Waylonis 1964;
Kimura 1972; Mitz et al. 1980).
Electromyography (EMG) involves the use of a needle electrode inserted into the muscles of
the face with the resulting electrical potentials displayed on an oscilloscope. Idiopathic facial
paralysis usually results in a decreased number of voluntary motor units which is directly
related to the number of nerve fibres involved in neurapraxia or axonal loss. After
approximately 10 to 14 days, facial muscles deprived of their innervation develop unstable
resting membrane potentials and begin to depolarise spontaneously. This is seen as positive
sharp waves and fibrillation potentials. When reinnervation begins, small polyphasic action
potentials may be seen. In recovery, these polyphasic potentials progress to become larger and
more prolonged, eventually resulting in a voluntary activation pattern with the number of
remaining fibrillation potentials reducing with time. Where recovery does not occur,
fibrillation potentials remain. The maintenance of voluntary motor units 72 hours after the
onset of idiopathic facial paralysis has been correlated with a good prognosis (Granger 1967;
Granger 1976). The use of EMG in predicting recovery of idiopathic facial palsy has been
criticised however. A few remaining motor units may suggest a favourable outcome when the
majority of the nerve has been destroyed. Furthermore, a few severed axons may yield a large
number of fibrillation potentials implying substantial denervation. May found that 75% of
patients with no voluntary motor units in the affected facial muscles had an incomplete
recovery at 6 months and that 38% of patients with no voluntary motor units in the affected
facial muscles had an incomplete recovery at 6 months (May et al 1983). He concluded that
EMG was an unreliable prognostic tool in idiopathic facial palsy. EMG remains, however, the
only objective way to document reinnervation, especially in the early stages of recovery.
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Compound muscle action potential recording of the facial nerve was popularised by Fisch for
prognostic purposes in Bell's palsy (Fisch 1981), although he referred to it as
electroneuronography (ENoG). This involves simulating the main trunk of the nerve at the
stylomastoid foramen and recording from an active surface electrode lateral to the nasal ala
and a reference surface electrode 18 mm inferior and lateral to the active electrode. With
stimulation, a compound muscle action potential can be recorded. Each side of the face is
stimulated and the peak-to-peak amplitudes are compared for both right and left sides. Fisch
recommended that in Bell's palsy, if 90% degeneration had occurred within two weeks of
onset of the paralysis (that is the evoked amplitude on the affected side was less than 10% of
normal), surgical decompression of the nerve should be carried out (Fisch 1981). These criteria
have however been questioned (May et al. 1986) and in the United Kingdom, surgical
decompression of the facial nerve in viral infections, is not generally practised. Comparing the
recorded amplitude and area of the compound muscle action potential have not yielded a
significant difference regarding the accuracy of predicting a functional outcome in idiopathic
facial palsy (Thomander & Stalberg 1981). This study also evaluated surface and needle
recording electrodes. Needle recording electrodes varied considerably and surface electrodes
were deemed more appropriate for recording purposes.
Maximum stimulation testing of the facial nerve was popularised by May et al (May et al.
1971). This is similar to the compound action potential recording except that the muscle
response is observed and not recorded electrically. This therefore does not require
electrophysiology recorders or oscilloscopes and can be carried out using a hand held
stimulator. This technique has been shown to be a good predictor of outcome in Bell's palsy.
The blink reflex is a contraction of the orbicularis oculi muscle resulting from electrical
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activation of the supraorbital nerve. It consists of two temporally distinct responses, the first,
an ipsilateral and the second, a bilateral response. The exact autonomic route is unknown.
Kimura et al used this procedure in 81 patients with Bell's palsy (Kimura et al 1976). In two
months all patients with an intact first, ipsilateral reflex recovered function whereas none of
the patients with an absent first, ipsilateral reflex recovered function. The study did not
continue after two months and the long term outcome of the patients with an absent first,
ipsilateral reflex is unknown.
All of the above electrophysiological tests which rely on stimulation of the facial nerve at or
distal to the stylomastoid foramen are only valid several days after the onset of Bell's palsy.
Stimulation of a nerve, distal to the site of injury will result in a normal response until
Wallerian degeneration (if it is going to occur) takes place. EMG does not rely on stimulation
of the facial nerve and may give an earlier indication of outcome than tests that do rely on
stimulation of the facial nerve directly. The blink reflex can also assess conduction across the
intracranial portion of the facial nerve.
It must be noted that the majority of work studying these electrophysiological tests relates to




When a peripheral nerve is divided (neurotmesis), Wallerian degeneration takes place distal to
the site of injury and the proximal nerve undergoes degeneration at least to the nearest node of
Ranvier, although greater degeneration can happen with more significant injury. The proximal
end of the severed nerve swells and there is proliferation of Schwann cells and fibroblasts. The
distal segment of the nerve loses its connection with the cell body and cannot maintain its
structural and functional integrity. Initially, the axon swells and myelin disintegrates into
droplets, being phagocytised by Schwann cells and macrophages. Wallerian degeneration is
characterised initially by a granular disintegration of axoplasmic microtubules and
neurofilaments, due to proteolysis. The collagen content of the distal segment is increased at
the basement membrane of Schwann cells. With collagen deposition in, and shrinkage of, the
endoneurial tubes, their size becomes considerably reduced. Rapid mitosis in Schwann cells
results in their proliferation and formation of Schwann cell columns (bands of Bungner). These
columns are important potential regenerative pathways for new axons and contain the
glycoprotein, laminin, on their basal laminae which promotes neurite growth. A critical phase
in nerve regeneration after repair is axonal sprouting across the site of injury. Initially, many
more axons will develop than previously existed in the healthy nerve. Many of these sprouts
will fail to make peripheral connections and die. Axons that do establish peripheral
connections will mature and enlarge, perhaps as a result of trophic substances from these
targets. Thus the number of axons distal to a nerve repair may not vary proportionally with
functional success of that repair, and indeed may indicate the opposite situation, with multiple
branching due to scar tissue. Neurones are destined to be either myelinated or unmyelinated. If
originally myelinated, axons will develop myelin, and similarly unmyelinated fibres will
remain as such, even when regenerating into a graft which was originally myelinated. Rates of
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growth vary after repair of neurotmeses. In the rat, a nerve will regenerate at approximately 3
mm per day (Forman et al 1979). In the human, repair occurs at approximately 1 - 2 mm per
day(Seddon 1975).
Classification of nerve injury
In the early 1940's, Seddon produced a classification of nerve injuries (Seddon 1943) which
has stood the test of time and is still used today.
Neurapraxia refers to a local conduction block in which the continuity of the axons, the
excitability of the nerve distal to the lesion, and of the muscle are preserved. Such a
conduction block is supposed to correspond to an acute local demyelinating block as
demonstrated after compression injury (Denny-Brown & Brenner 1944). This conduction
block persists until local myelin repair processes restore local excitability of the nerve fibre
and conduction is restored over the damaged segment. This may take weeks or months to
occur.
The next and more severe degree of nerve injury described by Seddon is axonotmesis,
implying a loss of continuity of axons although the endoneurial tubes are still intact. Wallerian
degeneration takes place. Recovery of function is good however as axons regenerate through
intact endoneurial tubes and specificity for target organs is preserved. This injury corresponds
to an advanced compression or traction injury.
Seddon's final classification of nerve injury is neurotmesis which he described as 'the nerve
that has either been completely severed or is so disorganised by scar tissue that spontaneous
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regeneration is out of the question' (Seddon 1975). This includes loss of continuity of some or
all of the remaining elements of the nerve trunk, including endoneurial tubes, perineurium and
epineurium. Surgical repair is required to improve chances of reinnervation.
In 1951, Sunderland introduced a further and more detailed classification of nerve injury
(Sunderland 1951). Sunderland types I and II correspond to Seddon groups, neurapraxia and
axonotmesis respectively, and neurotmesis corresponds to Sunderland type V. Sunderland
types III and IV lie somewhere between axonotmesis and neurotmesis and cannot be classified
under Seddon's system. A Sunderland type III injury implies loss of continuity of axons and
endoneurial tubes while the perineurium is still intact. The continuity and orientation of
endoneurial pathways are lost. The fibre disorganisation may be complicated by
intrafascicular bleeding, oedema and ischaemia and this lesion might easily lead to the
development of intrafascicular fibrosis. Sunderland type IV implies, in addition, loss of
continuity of the perineurium with preservation of the epineurium, while Sunderland type V
implies loss of continuity of the entire nerve trunk. The Seddon and Sunderland types of nerve






Neurapraxia I Local myelin damage with no Wallerian degeneration
Axonotmesis II Wallerian degeneration with endoneurial tubes intact
III Loss of axons and endoneurial tubes
Perineurium intact
IV Loss of axons, endoneurial tubes and perineurium
Epineurium intact
Neurotmesis V Transection of the entire nerve trunk
Table 1.2 classi ication of nerve injury
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Nerve repair
The first case of peripheral nerve repair is attributed to Ferrara in 1608 although it was not
until the second world war that most of the pioneering work on this subject was recognised
(Young & Medawar 1940) and notably in the middle of this century by Seddon (Medical
Research Council 1954). The operating microscope transformed nerve repair into the technical
skill of microsurgery and with it, evidence from experimental studies arose as to which
surgical techniques gave the best results. The 'gold standard' of nerve repair is direct, tension-
free suture of the proximal and distal nerve stumps. The classic method of suture is the
epineurial suture, although in order, more correctly, to achieve orientation of nerve fasicles,
'fasicular repair' offers a theoretical advantage. The technique of fasicular repair inevitably
requires resection of the epineurium and perineurial suturing which may lead to further trauma
and could thus compromise healing. Direct suture of nerve stumps is not always possible.
Damaged or lacerated nerve should be resected until healthy nerve can be defined and sutured.
Again, tension should be avoided as should excessive mobilisation of nerve which can result in
ischaemia. Thus autologous nerve grafting is an important technique in nerve repair and
remains the ideal where there is insufficient length to suture proximal and distal nerve stumps
directly. Nerve grafting, however, necessitates the sacrifice of a sensory nerve (often sural or
greater auricular). Where the donor nerve is of insufficient diameter to support the injured
nerve, 'cable' nerve grafting, where several strands of the nerve graft are arranged in parallel
to make up the required cross section was devised (Kilvington 1908). A cable graft involves
an epineurial repair, where as an interfasicular graft involves several donor nerve strands
bridging a gap, and sutured in a fasicular repair. Recently the use of freeze-thawed muscle
grafts have been evaluated in a large animal model (Glasby et al. 1995; Lawson & Glasby
1995) with good results over short distances.
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Injury to the facial nerve in mastoid and middle ear surgery is uncommon, however
mastoidectomy with or without tympanoplasty is the most common procedure resulting in
iatrogenous facial nerve injury (Green et al 1995). Facial nerve injury is a devastating blow to
both patient and otological surgeon. Injuries occur even in the hands of the most experienced
surgeons. Contributing factors may be an aberrant facial nerve, granulation tissue,
cholesteatoma, and revision surgery where anatomical landmarks may no longer exist. Most
experts agree that immediate facial paralysis after otological surgery, which fails to recover in
a few hours, should be surgically explored (Glasscock et al. 1979). The House Ear Clinic in
California published a study of 22 patients undergoing surgery for a iatrogenous facial nerve
injury (Green et al 1994), all but one patient having been a tertiary referral. All patients had
complete paralysis (House-Brackmann grade VI). The most common location for injury to the
nerve was in the lower tympanic segment (55% of patients). Four patients had multiple injured
segments of the nerve and one patient had an injury extending from the stylomastoid foramen
to near the geniculate ganglion. Ten patients underwent facial nerve grafting and three patients
had a direct repair. Repair was either by fine monofilament suture or juxtaposition of the
nerve ends within the Fallopian canal. The final result of nerve grafting (n=9) was a House-
Brackmann grade of IV in 78% of patients (22% achieved grade III). With primary repair, all
patients (n=3) achieved a House-Brackmann grade of III.
Neurotrophic factors
The term 'nerve growth-promoting substance' was introduced in 1954 to describe a substance
isolated from mouse sarcomata 180 and 37 which enhanced growth and differentiation of
sensory and sympathetic neurones (Cohen et al 1954). Shortly thereafter more potent sources
of this factor were discovered in snake venom and in mouse salivary glands (Cohen & Levi-
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Montalcini 1956; Levi-Montalcini & Cohen 1956). This factor, identified as a protein became
known as 'nerve growth factor' or 'NGF' (Cohen et al 1954). In 1986, Levi-Montalcini and
Cohen shared the Nobel Prize for physiology or medicine for the discovery. Since then many
other neurotrophic factors have been identified with profound effects on the vertebrate nervous
system. Brain-derived neurotrophic factor (BDNF) was identified in 1982 (Barde et al 1982)
and ciliary neurotrophic factor (CNTF) two years later (Barbin et al. 1984). The key
discovery that BDNF was structurally related to NGF led to the discovery of NT 3 and NT
4/5. This family of molecules is now termed the 'neurotrophins' (Hohn et al. 1990). Other
previously identified growth factors were found to regulate neuronal survival in vitro and
therefore can be considered neurotrophic. These include fibroblast growth factor (FGF),
epidermal growth factor (EGF) and insulin-like growth factor (IGF). Another neurotrophic
factor is glial-derived neurotrophic factor (GDNF). Despite the name 'growth factor' there is
little evidence that these agents act as more than survival-promoting factors. The definition of
trophic factors excludes membrane-bound molecules that affect adhesion and survival of
neurones as well as non-protein compounds such as thyroid hormones, steroids and
gangliosides. The definition of a neurotrophic factor as discussed further in this text will be 'a
soluble protein regulating survival, growth, morphological plasticity, or synthesis of proteins
for differentiated functions of neurones' (Loughlin & Fallon 1993). The experimental evidence
for the effects of neurotrophic factors comes from various sources. Much work has
concentrated on in vitro studies of cell cultures. Other work exists using embryonic and
neonatal mammals as experimental models for neurotrophic action. Evidence can also be
obtained from genetically modifying animals to be deficient in the gene responsible for a
neurotrophic factor's production and thereafter assessing development. Most relevant to the
human is experimental adult animal work.
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Since its discovery in 1954, most experimental work on neurotrophism has involved NGF.
The molecular structure of NGF has been determined with its amino acid sequence. The
activity of NGF was initially established for neural crest-derived sympathetic and sensory
neurones and the growth-cone of such a transected nerve on media enriched with NGF shows
massive proliferation (figure 1.1)
Figure 1.1. Nerve growth cone on NGF enriched media.
NGF supports neurite growth, but neither survival of ventral spinal cord neurones in vitro
(Longo et al 1982; Wayne & Heaton 1990) nor in vivo (Oppenheim et al. 1988). Hughes et al
showed that NGF failed to support cultured embryonic rat motor neurones above control
levels, even at high concentrations (lOOng ml"1) (Hughes et al 1993). In vivo, after nerve
transection in neonatal rats, NGF administration causes a greater loss ofmotor neurones, but
an attenuated loss of sensory neurones (Miyata et al. 1997). NGF can also spare the death of
adult sensory neurones (Rich et al. 1987).
16
BDNF shares about 50% similarity to NGF at the amino acid level in various mammalian
species (Thoenen 1991). These amino acids are not randomly distributed, but are concentrated
in conserved domains that include six cysteine residues, which form disulphide bridges which
determine the molecule's three-dimensional shape. Despite the similarities between NGF and
BDNF, these molecules show different neuronal specificities. BDNF is found in higher
concentrations in the adult brain. In vitro, BDNF promotes the survival of embryonic retinal
ganglion cells (Barde 1989) and mesencephalic dopaminergic neurones (Flyman et al. 1990),
which are not supported by NGF. In vitro and in vivo, BDNF supports the survival of
embryonic sensory neurones (Lindsay et al 1985). Neurotmesis-induced motor neurone death
in neonatal mice is almost completely prevented by local application of BDNF, which occurs
with NGF but to a lesser extent (Li et al. 1994) - 5 pg of growth factor applied to the
proximal nerve stump. In neonatal rats, neurotmesis-induced facial motoneurone death can be
partially prevented by administration of 5 pg of BDNF, whereas no effect was seen with NGF
in a similar concentration (Sendtner et al. 1992). In adult mammals, transection of the
hypoglossal nerve results in a dramatic loss of choline acetyltransferase (ChAT) in the
hypoglossal motor nucleus. This injury-induced reduction in ChAT is prevented when 50 pi
solution of BDNF is applied to the proximal end of the transected nerve (Chiu et al 1994).
When CNTF is similarly applied, ChAT levels are not maintained. In mice genetically altered
to lack the BDNF gene, no loss of motor neurones was found compared to a reduction in the
number of sensory neurones (Liu et al. 1995). This suggested that BDNF was not essential for
motor neurone development and survival although it does not rule out its role in other aspects
ofmotor neurone function.
NT 3 was identified in 1990 by polymeraze chain reaction techniques (Flohn et al 1990) and
shows strong similarities to NGF and BDNF. In contrast to NGF and BDNF however, NT 3
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is not predominantly expressed in the central nervous system but in peripheral tissues such as
skeletal muscle, liver and gut (Thoenen 1991). In the CNS, NT 3 is found mainly in the
hippocampus and cerebellum (Maisonpierre et al. 1990). In contrast to BDNF it is found in
highest concentrations during development. It can support embryonic sensory neurones in
vitro (Lindsay et al 1985) and in vivo (Hofer & Barde 1988). NT 3 can also rescue virtually
all neurotmesis-induced motor neurone cell death in the neonatal mouse, with effects similar to
BDNF (Li et al 1994). In a similar study Sendtner et al, showed NT 3 could prevent the death
of new-born rat facial nerve neurones although these effects were substantially less than the
effects ofBDNF (5 pg ofNT 3 and BDNF was used) (Sendtner et al 1992).
NT 4/5 is another member of the neurotrophin family of molecules. NT 4/5 has been shown,
like BDNF, to prevent injury-induced cell death in neonatal rats by its local application to the
proximal nerve stump after neurotmesis, with 20pg (Koliatsos et al. 1994) and 1 Opg (Hughes
et al 1993) applied to the nerve stump. Where the NT 4 gene was genetically deleted in mice,
the facial motor nucleus and sympathetic neurones of the superior cervical ganglion were
unaffected. In contrast there was a loss of sensory neurones, similar to results of genetically
depleted BDNF mice (Liu et al 1995), again suggesting that NT 4 is required during the
development for the survival of some peripheral sensory neurones but not sympathetic or
motor neurones.
Ciliary neurotrophic factor was first identified and partially purified from embryonic chick eye
tissues. Later, it was shown to be present in large amounts in sciatic nerves of adult rats and
rabbits. This finding led to its final purification and cloning. Human CNTF shows 84%
homology with rat CNTF and has no similarities to the neurotrophin family of molecules.
CNTF is produced in the nerve and does not originate from retrograde transport. The target
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organ is therefore not a source of CNTF in motor neurones innervating skeletal muscle. In
new-born rats CNTF mRNA cannot be detected and high levels are not reached until the
fourth postnatal week. This lack of CNTF mRNA parallels the differentiation of Schwann
cells in the nerve. CNTF is not secreted by the classical pathways of the endoplasmic
reticulum and Golgi complex, but is present in high quantities within the cytoplasm of
myelinating Schwann cells and astrocytes (Sendtner et al 1994). It has been suggested that this
would allow the molecule to act after cell damage (Barde 1994) although it may simply be that
its secretion is facilitated by an, as yet, unknown mechanism. The regulation of CNTF in the
peripheral and central nervous systems is very different. After a central lesion, CNTF mRNA
is rapidly up-regulated and levels are maximal at three days after injury and remain elevated
for at least three weeks. The CNTF seems to be produced by astrocytes around the wound
cavity. Conversely, in the peripheral nervous system, CNTF mRNA levels drop rapidly to less
than 5% within the first week after a nerve lesion. These levels slowly recover, with the first
signs of CNTF mRNA being detectable by in situ hybridization 1 week after the lesion. Four
weeks after the lesion there is then a significant rise in CNTF mRNA. CNTF has a broad
spectrum of in vitro effects. These include the promotion of survival of ciliary, sympathetic,
sensory, nodose, trigeminal and spinal motor embryonic chick neurones. Hughes et al, failed
to show any significant survival benefits above the control group in cultured rat motor
neurones (with concentrations of 100 ng ml"1) (Hughes et al 1993). In vivo CNTF increases
the number of spinal motoneurones in E5 and E9 (embryonic day 5 and 9) chicks, but does not
alter the number of sympathetic, sensory and nodose neurones. Furthermore, Sendtner et al
showed that more than 80% of new-born rat facial motor neurones die one week after
neurotmesis (Sendtner et al 1990). When CNTF was administered (5 pg) locally to the
transected facial nerve, death of the motor neurones in the brain stem was prevented. Newman
et al applied CNTF (600 pg over 4 weeks) to repaired rat sciatic nerves in an osmotic pump
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and used muscle mass and sciatic function index to assess recovery (Newman et al. 1996).
They suggested a significant improvement with the CNTF treated group compared to the
control group. This suggests that CNTF may be a 'lesion factor' for damaged motor neurones.
In contrast to the apparent efficacy of CNTF, Winter et al reported results of a study where
motor neurone degeneration mutant mice, which harboured a transgene resulting in the
overproduction of CNTF, showed an increase in signs of motor neurone degeneration instead
of any beneficial effects (Winter et al. 1996).
GDNF is a member of the transforming growth factor-B superfamily of molecules and was
initially identified as a neurotrophic factor for substantia nigra dopaminergic neurones (Lin et
al. 1993). It is retrogradely transported by spinal cord motor neurones, but not sympathetic
neurones, in neonatal rats and local application (approximately 20 pg) of GDNF to the
transected facial nerve prevented neurotmesis-mediated cell death in the neonatal period. In
adult rats locally administered GDNF was found to attenuate the lesion-induced decrease of
ChAT in the facial nucleus (Yan et al 1995).
Bothwell first observed the response of neurite outgrowth to insulin-like growth factor (IGF)
(Bothwell 1982). Low concentrations of IGF have been shown to enhance the survival of
cultured embryonic sensory and sympathetic cells (Recio-Pinto et al 1986). In vivo
experiments have shown IGF-1 infusion increased regeneration of sensory and motor axons in
divided sciatic nerves (Kanje et al. 1989; Near et al. 1992). In situ hybridization has shown
that IGF mRNA is up-regulated in the distal, but not the proximal nerve (Pu & Ishii 1993). It
is possible that this creates an IGF concentration gradient greatest at the distal nerve segment
and thus helps to stimulate and guide nerve regeneration. As well as neurotrophic factors
acting on nerves, IGF has a role as a mitogen and a growth factor on target tissues and thus
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differs from a classical neurotrophic factors such as NGF. This dual role of IGF may function
in development to co-ordinate growth between the size of the nervous system and the size of
the end organ which is to be innervated (Ishii et al 1997).
Less work has been concentrated on epidermal growth factor (EGF) and fibroblast growth
factor (FGF), although FGF has been reported to promote motor neurone survival in vitro
(Arakawa et al 1990; Henderson et al. 1993) although it was found to be ineffective in
preventing mouse motor neurone cell death after neurotmesis (Li et al 1994).
From a consideration of the research into neurotrophic factors it can be seen that much effort
has been concentrated on promoting the survival of cell bodies of transected neurones in
embryonic and neonatal animals. Other research has concentrated on survival of tissue
cultures of neurones. These situations are far removed from the reality of nerve repair and the
ideal of potentiating the functional outcome of nerve coaptation or treatment of neurological
disorders such as motor neurone disease. Many of the published studies end by suggesting that
the effects of neurotrophic factors are potentially beneficial in these disorders. There is a
paucity of research in the area of nerve coaptation with neurotrophic factors and what does
exist places great emphasis on nerve morphology, even though this may not be the best
indicator of functional outcome. Moreover, some studies are contradictory and no
neurotrophic factor clearly stands out as superior to all others. NGF does appear, however, to
support sensory neurones rather than motor neurones. It would appear therefore, that more
research is needed into the use of neurotrophic factors in a surgical model of nerve repair. In
vitro and embryonic and neonatal research is interesting and suggests avenues of study but
extrapolation to adult mammalian models, let alone the human, is not necessarily valid. The
assessment of outcome of nerve repair is paramount. It is likely that any benefit derived from
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the use of neurotrophic factors in nerve repair will be small, although if present it may still
represent clinically useful improvement. With the severe limitations of clinical testing of
muscle function in the animal model, electrophysiology (by evoked electromyography) as well
as nerve and muscle morphology offers the best assessment of reinnervation of the motor unit.
Conclusion
A normally functioning facial nerve is vital to a person's well being and self-esteem. Injury to
the nerve is uncommon but devastating. Nerve repair is a well tried and accepted surgical
procedure and offers a chance of recovery of some function, but even in the hands of super-
specialists, results are far from good. Neurotrophic factors are powerful endogenous
molecules and in vitro can influence growth and survival of neurones.
The question remains therefore: do the currently identified neurotrophic factors, if
administered exogenously, offer any benefit in the outcome of surgical nerve repair? The







Properties of the tube
Methods
Introduction
It has long been believed that the repair of a defect in a length of nerve is best undertaken by
autologous nerve grafting. However, much attention has been concentrated on entubulation of
nerve ends as a method of repair. Similarly, although it is accepted that the repair of
neurotmesis is best achieved by epineurial or fasicular suture of the nerve ends, some authors
advocate entubulation in preference to direct suture repair and clinical studies have been
carried out where substantial series of patients have undergone this technique with good
functional results.
The problems with autologous nerve grafting have fuelled the search for other techniques of
repairing nerve defects. The harvesting of donor nerve leaves a scar, a sensory deficit and
occasionally, a painful neuroma. The idea of bridging the ends of a defect in a nerve by a non-
neural tube is not a novel one. Experimental work with animals was first reported by Gliick in
1880 and again in 1882 (Gliick 1880; Vanlair 1882). Both of these reports used decalcified
bone as a conduit. Since then, arteries (Foramitti 1904), veins (BenitoRuiz et al. 1994),
amnion (Chao et al 1962), fascia (Lundborg & Hansson 1980) and a variety of synthetic
materials (Giardino et al. 1995) have been employed in an attempt to find the ideal material.
Apart from the absence of donor site problems, the use of entubulation over autologous nerve
grafting offers other theoretical advantages. The avoidance of trauma to the nerve endings by
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suture, and the tissue reaction this might provoke may be a beneficial effect of entubulation.
The tube may also act to confine the nerve endings and stop neurites being lost to non-target-
organ tissues. Last, the tube may prevent fibroblasts entering the site of nerve repair which
could hamper regeneration and maintain an optimal microenvironment for nerve growth,
perhaps with the concentration of neurotrophic factors around the site of repair. The cellular
mechanisms for the establishment of nerve-to-nerve continuity within a silicone tube after
neurotmesis has been studied by Schroder et al (Schroder el al 1993). At three days after
surgery to create a 1 cm nerve defect in a rat sciatic nerve, a meshwork of fibrin had
precipitated in the tube bridging the proximal and distal nerve stumps. Contained in this
meshwork were erythrocytes, granulocytes, thrombocytes and some macrophages. Fibrin was
mainly arranged longitudinally and there was a narrow cleft between the cord of tissue and the
wall of the tube. This cleft had increased in size by seven days after surgery, owing to
retraction of the fibrin clot, and there were bipolar cells arranged longitudinally on the outer
part of the cord. Perineurial cells closed the gap between nerve stumps at 18 days and
Schwann cells, fibroblasts and blood vessels occupied the centre of the cord. By three weeks
after creation of the neurotmesis and gap, axons from the proximal nerve stump had reached
the distal stump although they were, as yet unmyelinated. It is thought that the perineurium
serves as a diffusion barrier from the outside as well as from the inside of the nerve fascicle,
thus providing an endoneurial environment for the developing nerve (Dyck et al. 1984; Klemm
1970).
Type of tube
Many types of tubing have been suggested for nerve repair. Lundborg has much experience of
nerve repair and is an advocate of silicone as an ideal material for entubulation (Lundborg et
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al 1991). Yet in clinical practice, two out of three of Lundborg's nerve repairs with silicone
have required a 'second look' procedure for 'irritation' around the site of repair. Although the
authors discount the importance of this, it would clearly be undesirable and cost ineffective for
revision procedures to be required after nerve entubulation with silicone. Most experts now
agree (Dellon 1994) that a biodegradable conduit is the method of choice if entubulation for
nerve repair is to be considered.
Entubulation
In 1981 Lundborg et al showed that the proximal stump of a rat sciatic nerve would
regenerate diagonally through the rectangular space of a silicone chamber to meet with a distal
nerve stump (Lundborg et al. 1981). Since then many authors have published their success
with entubulation using other materials and other nerves. Lundborg and Hansson successfully
used pseudosynovial tubes, formed from the tissue reaction around a silicone rod, to bridge a
nerve gap. A thin spiral of metal wire was used to prevent collapse of the tube (Lundborg &
Hansson 1980).
Pham et al compared the standard sutured epineurial repair of the rat peroneal nerve to repair
with a polyglycolic acid tube and collagen glue (Pham et al. 1991). Assessment of recovery
was by nerve morphology and electrophysiology and significantly better conduction was found
in the entubulation group compared with the sutured group. There was no difference in nerve
morphology between groups. Hentz et al used polyglycolic acid tubes as a pseudoperineurium
in an attempt to isolate the functional intrafasicular tissues from the extrafasicular
fibroreactive process (Hentz et al. 1991). In this non-human primate study median and ulnar
nerves were repaired by the three techniques of epineurial and fascicular repair and fascicular
tubulization. This showed no significant difference between the three types of repair. Other
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authors (Rosen et al 1989; Stevenson et al 1994) have similarly, failed to show a difference
either physiologically or histologically between these three types of repair.
One of the most interesting concepts to be considered with nerve repair is whether
entubulation with the deliberate creation of a small nerve defect of 3 to 5 mm, where
epineurial suture would be possible, is the optimal management (Dellon 1994). This idea has
the theoretical advantage of providing an optimal microenvironment for nerve regeneration
and repair and potentially concentrating neurotrophic factors in the gap between the nerve
stumps.
Properties of the tube
If the microenvironment at the site of nerve regeneration is indeed important, the permeability
of the tube may also have an impact on functional outcome. In the assessment of repair of
nerves with a 1 cm defect, macropore collagen conduits give greater functional recovery than
either semipermeable or non-permeable collagen tubes (Kim et al. 1993). It is postulated that
the macropore tube allows neurotrophic factors, being macromolecular proteins, to gain
access to the nerve repair site. The internal diameter and wall thickness of the nerve conduit
also appear to influence nerve regeneration (Den Dunnen et al. 1995). The tube must be large
enough to accommodate any swelling of the nerve and not itself cause compression of the
nerve by swelling when the tube degrades or the nerve grows.
From the above evidence it follows that the ideal nerve conduit should be biodegradable,
provoking little or no inflammatory response and should not collapse or swell during
degradation. It should be able to be manufactured in a range of sizes depending on the
diameter of nerve to be repaired. A material that meets these requirements is a controlled
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release glass (CRG). This is composed of inorganic polymers, normally based on phosphates
of sodium and calcium, which have been converted to a glassy form by melting the
constituents at about 1000 °C. They dissolve completely in water leaving no solid residue. The
rate of solution can be selected by adjustment of the composition and physical form of the
CRG and is constant for as long as any of the material remains. The product can be produced
in many physical forms; as powder or fine granules, fibre or cloth, tubes or as cast blocks of
various shapes. Elements other than sodium and calcium, including most metals and their
oxides and a limited number of inorganic anions, can be included in the composition of the
glass. These elements which may be biologically active can then be delivered at a constant rate
into an ambient aqueous medium as the CRG dissolves. This has found application in
veterinary medicine as a means of delivering such diverse substances as trace elements,
anthelmintics and vaccines. In the course of development the biocompatibility and absence of
toxicity of CRG based on Na20-(Ca,Mg)-0-P205 with and without other constituents have
been investigated. In applications differing as widely as use in orthodontic devices (Savage
1982), in nutritional experiments with rats and in controlled supply ofCu, Co and Zn in cattle
(Drake & Allen 1985), no ill effect were observed. When CRG pellets were implanted
subcutaneously, intramuscularly and intraperitoneally in rats, sheep and cattle, reaction at the
implant site was limited to a sterile fibrous encapsulation less well developed than that
expected from biocompatible surgical materials (Allen et al. 1978). Other applications of
CRG in the Na20-Ca0-P205 system have been found as potential bone graft adjuncts or
substitutes. No sign of cytotoxicity was observed in mouse fibroblasts (Docherty 1982) or
after soft tissue implantation in sheep (Burnie et al. 1981). In further experiments with bone
no ill effects nor bio-incompatibility could be detected (Burnie 1982; Burnie et al. 1983;
Burnie & Gilchrist 1983; Duff et al. 1984).
27
Methods
A CRG tube was used in entubulation experiments. In the sheep experiments (chapter 4) the
tube was manufactured 3 cm in length with an external diameter of 10 mm and an internal
diameter of 7 mm. In the centre of the tube, a hole was drilled by a high speed dental burr to a
diameter of 1 mm. A plastic catheter (Charles River UK Ltd, Kent, UK) was then inserted into
the CRG tube and this was glued in position (Loctite 406). The tubes with catheters were
sterilised by gamma irradiation (Figure 2.1) and they were stored, ready for entubulation of
the buccal branch of the facial nerve (chapter 4) in the sheep. The plastic catheter was
attached to a 2 ml Alzet osmotic pump (Charles River UK Ltd, Kent, UK) which was filled
with saline as a control or neurotrophic factors. This osmotic pump is an implantable device in
which a compressible reservoir is surrounded by a rigid semi-permeable membrane. Over a set
period of time after implantation, the semi-permeable membrane allows water to diffuse
through the outer casing of the pump compressing the reservoir and delivering the contents of
the reservoir via a tube to the site of intended action. Pumps are available in different
capacities and duration of delivery of their contents.
28
1 cm






The anatomy of the rat facial nerve
Method of procedure
Introduction
The rat was used as one of the experimental animals for the investigation of the effects of
nerve entubulation and neurotrophic factors on nerve repair. The rat is a commonly used
laboratory animal and its use was within the financial resources of this study. Several groups
of operations were performed, the purpose of which was to establish if entubulation nerve
repair and entubulation repair and administration of neurotrophic factors had a measurable
effect on nerve regeneration. There were six rats in each group. These groups are shown in
table 3.1. After three months all rats from each group were re-operated on to obtain
electromyography and nerve morphometry.
Group no. Number of rats Procedure Time to assessment
1 6 N-N suture 3 months
2 6 N-N defect (4 mm glass tube) 3 months
3 6 N-N defect (4 mm glass tube,
with 10 pg BDNF)
3 months
4 6 N-N defect (4 mm glass tube,
with lOpgCNTF)
3 months
5 6 N-N defect (4 mm glass tube,
with lOpgGDNF)
3 months
6 6 N-N defect (4 mm glass tube,
with 10 pg NT 4)
3 months
7 6 N-N suture (10 pg BDNF and 10
pg CNTF to repair site)
3 months
8 6 N-N suture (10 pg GDNF and 10
pg NT4/5 to repair site)
3 months
Table 3.1. N-N = nerve-to-nerve
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The anatomy of the rat facial nerve
The rat has been used as an animal model for surgical manipulation of the facial nerve
(Mountain et al. 1993; Murray et al 1994). Mattox and Felix described the surgical anatomy
of the rat facial nerve in detail, after microscopic dissection of ten animals (Mattox & Felix
1987). Previous texts on this subject were contradictory (Greene 1955; Hebel & Stromberg
1976). Mattox and Felix described that the nerve exits the stylomastoid foramen on the lateral
side of the skull, posterosuperior to the external auditory canal (Mattox & Felix 1987). The
posterior auricular branch diverges from the facial nerve as it leaves the stylomastoid
foramen. The nerve trunk passes anteroinferiorly between the trapezius muscle and the
external auditory canal. The first 2 mm of the nerve is covered by the cervical head of the
trapezius muscle. Underlying the nerve trunk and separated by a thin fascia, the common
trunk of the occipital and post-auricular arteries pass as they travel to the pina. The total
length of the main trunk of the nerve (not including the posterior auricular branch) is 6 mm
before its furcation.
The facial nerve divides into six branches. The furcation is obscured by the posterior facial
branch of the external jugular vein (figure 3.1). This vein is a substantial vessel and drains the
majority of the head, as the rat has no internal jugular vein. The external jugular vein passes
lateral to all branches of the nerve except for the small, posterior cervical branch, which
passes lateral to the vein. The internal maxillary and masseteric veins pass medial to the















All peripheral branches of the facial nerve lie beneath the superficial fascia covering the facial
musculature. As in other rodents, the nerve passes beneath, not within, the parotid gland.
There are six branches of the facial nerve (figure 3.2):
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The posterior auricular branch diverges from the facial nerve as it leaves the stylomastoid
foramen and supplies the auricular muscles.
The posterior cervical branch is the first branch of the furcation and consistently passes lateral
to the external jugular vein.
The cervical branch is the most posterior and inferior branch beneath the external jugular vein.
It separates immediately from the mandibular branch, not midway as previously described
(Greene 1955; Hebel & Stromberg 1976).
The mandibular branch is the largest branch of the facial nerve. It crosses the lower central
portion of the masseter muscle and extends for 10 - 12 mm before branching into the
musculature of the upper and lower lips.
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The buccal branch of the nerve follows the grove between the masseter and the temporalis
muscle. It passes beneath the eye and towards the nose and also sends branches to upper and
lower lips. The auriculotemporal branch of the trigeminal nerve runs in close proximity to the
buccal branch of the facial nerve 2-4 mm from the furcation. The two nerves can, however,
be dissected apart with the aid of the operating microscope. Peripherally, the trigeminal fibres
supply the skin in the area of the vibrissae.
The temporal and zygomatic branches may arise from the furcation or from the buccal branch.
They have short and complex branching patterns. This, and their intimate relationship with the
tributaries of the external jugular vein make them unsuitable for surgical manipulation.
Mattox and Felix also performed axon counts of the rat facial nerves under study (Mattox &
Felix 1987). A mean value of 4650 axons were counted in the main trunk of the nerve. In the
buccal division, a mean value of 1955 axons was obtained with a 13.7% mean difference
between right and left sides.
Method of procedure
Anaesthesia
The rats were operated on under general anaesthesia achieved by halothane inhalation with air
as a vehicle gas. The animals were placed in Perspex chamber and induction of anaesthesia
was carried out with 4% halothane. Anaesthesia was achieved in 1 - 2 minutes and the rat was
removed from the chamber and placed on an operating bench. Anaesthesia was maintained by
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1.5% halothane administered by face mask, with a coaxial scavenging system (Hunter et al
1984) used to collect anaesthetic gases throughout surgery.
Surgery
The animal's fur on the left side of the face was shaved with electric clippers and the skin was
cleaned with a povidone-iodine antiseptic solution (Betadine, Seton Health Care, England).
Sterile drapes were used to mask the area not within the operative field and sterile instruments
were used in the operation. An incision was made below the lower border of the mandible and
the skin was retracted until the buccal division of the facial nerve was seen. The buccal
division of the nerve was dissected from the groove in the muscle were it lay. Approximately 1
cm of nerve was dissected. The extra-orbital lacrimal gland was reflected on its upper pole to
expose this length on nerve. It was not necessary to remove the gland.
GROUP 1
The nerve was transected using microscissors and a 2 mm length of the nerve was removed for
histological analysis (chapter 6). Surgery was carried out using an operating microscope
(Wild, Heerbrugg M690) with stepless variable magnification of 3.5 to 18 times. An
epineurial repair was performed, without tension, with three 10/0 nylon (Ethilon, Ethicon)
equally spaced, interrupted, circumferential sutures.
GROUP 2
The nerve was transected using microscissors and 4 mm of the nerve was removed for
histological analysis (chapter 6). The cut nerve was then placed in a CRG tube, which had
been sterilised by gamma irradiation. The nerve was held in position with a 10/0 Ethilon
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suture transfixing the epineurium of each nerve stump. The suture was tied so that the gap
between the stumps was 4 mm (as shown in figure 3.3). The middle of the tube was placed









4 mm nerve gap
Figure 3.3 Entubulation repair of the buccal division of the facial nerve in the rat.
GROUP 3
An area between the scapulae of the rat was also shaved and prepared in a similar manner to
the face. The buccal division of the facial nerve was transected using microscissors and a 4
mm length of the nerve was removed for histological analysis (chapter 6). The cut nerve was
then placed in a CRG tube and held in position with a 10/0 Ethilon, epineurial suture holding
each nerve stump. The suture was tied so that the gap between the stumps was 4 mm. The
glass tube had a 1 mm central, drilled hole, through which a plastic catheter had been glued.
Beforehand, the tube and catheter had been sterilised by gamma irradiation. The middle of the
glass tube was then positioned over the site of the nerve defect. The glass tube was sutured to
the underlying fascia with 4/0 Vicryl. An incision was made between the scapulae of the
animal and a subcutaneous pocket was created in the rat's back. This pocket was extended
rostrally in a subcutaneous tunnel to communicate with the facial incision. The plastic
catheter, which was attached to the CRG tube was led through this tunnel. The catheter was
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attached to a miniature osmotic pump (0.2 ml, Alzet, Charles River, Kent) which was filled
with 10 pg of BDNF dissolved in sterile water. The osmotic pump was placed in the pocket in
the rat's back and this was closed by interrupted 4/0 Vicryl sutures.
GROUP 4
The animals in this group were operated on in an identical manner to the animals in group 3
with the exception that 10 pg ofCNTF was used in place of 10 pg ofBDNF.
GROUP 5
The animals in this group were operated on in an identical manner to the animals in group 3
with the exception that 10 pg ofGDNF was used in place of 10 pg ofBDNF.
GROUP 6
The animals in this group were operated on in an identical manner to the animals in group 3
with the exception that 10 pg ofNT4/5 was used in place of 10 pg ofBDNF.
GROUP 7
The animals in this group were operated on in an identical manner to the animals in group 1
except that no glass tube was used and the nerve was repaired by circumferential epineurial
sutures, as in group 1. The catheter was connected to an ultafine needle and this was place in
the distal part of the nerve, 5mm from the repair site (figure 3.4). 10 pg of BDNF mixed with
10 pg ofCNTF was used in the osmotic pump.
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GROUP 8
The animals in this group were operated on in an identical manner to the animals in group 1
except that no glass tube was used and the nerve was repaired by circumferential epineurial
sutures, as in group 1. The catheter was connected to an ultafine needle and this was placed in
the distal part of the nerve, 5mm from the repair site (figure 3.4). 10 pg ofGDNF mixed with
10 pg ofNT4/5 was used in the osmotic pump.
Figure 3.4 Nerve repair in the rat without glass tube
The facial incision in all groups was closed with 4/0 continuous Vicryl to the platysma
muscle. 4/0 interrupted Vicryl was used to close the skin superficially with the knot buried.
The closed incision was covered with an antiseptic vapour-permeable dressing spray (Opsite,
Smith and Nephew, England). A single dose of subcutaneous enrofloxacin (0.1 ml) was
injected as a prophylactic antibiotic. Each rat's ears were clipped to allow identification and
this made possible a comparison of the nerve histology before and after nerve repair. Recovery
took approximately ten minutes, after which the animal was returned to a cage alone and




observed for a further 30 minutes. Once complete recovery had occurred the animal could
again be housed with other rats. The rats were checked daily for signs of wound infection
although they had little difficulty establishing normal behaviour and eating patterns. Because
the incision to expose the facial nerve was located below the mandible, and a musculo¬
cutaneous flap had been raised to expose the buccal division of the nerve, once the flap was
replaced and the incision closed, the site of nerve repair or entubulation was well protected.
This allowed nerve entubulation to be carried out with no extrusion of the CRG tube.
Three months after the original surgery each group of rats was re-operated on. General
anaesthesia was carried out as above. After collection of the electrophysiological data (chapter
8) 5 mm of the buccal division of the left facial nerve (distal to the site of repair) was







Large animals are more representative of the human than small animals such as rodents. The
physiology of nerve repair is more similar to the human in the sheep than it is in the rat. Much
research has therefore concentrated on the sheep as an animal model for nerve repair (Glasby
et al. 1990; Hems et al 1994). The use of the sheep, however, brings with it complexities to
experimentation that are not present in the rodent. Larger animals are more expensive to buy
and maintain. Whereas small animals can be housed in an animal area for the duration of the
study, sheep require to be transported to the animal area before and after surgeiy, with
sufficient time given for the animal to acclimatise to a new environment. This time to allow the
animal to 'settle in' reduces the stress on the animal and is required by law (Animals
(Scientific Procedures) Act, 1986). Anaesthesia is more complicated and particularly difficult
in ruminant animals because of gaseous build-up in the rumen and its associated problems.
Anaesthesia in these animals also necessitates endotracheal intubation, intravenous access
and, in many cases, intraarterial blood pressure monitoring. Because sheep are more
representative of the human model, the sheep was used in this study to investigate the effect of
various neurotrophic factors on nerve repair.
The anatomy of the extra-temporal facial nerve in the sheep is similar to the human. In the
sheep the nerve exits from the stylomastoid foramen at the skull base and courses rostrally to
enter the parotid gland where it divides into its terminal branches. The buccal branch of the
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nerve lies on the masseter muscle approximately half way between the horizontal process of
the mandible (which it runs parallel to) and the medial canthus of the eye. The distance from
the origin of the nerve at the base of the skull and the distal buccal branch, before it enters its
target muscles, is approximately fifteen centimetres and is thus suitable for the measurement
of various electrophysiological variables. The buccal branch of the nerve supplies small
muscles of the face of which the depressor labii maxillaris is most accessible to
electromyographic study. This muscle acts as a guy-rope to anchor the upper lip and is
uniquely supplied by the buccal branch of the nerve. The recording electrodes were placed
over the tendon and the muscle belly. Three groups of sheep (five to six sheep per group) were
studied. First, a group of sheep underwent neurotmesis of the buccal branch of the facial nerve
with immediate, tension free repair by epineurial suture (Group 1). Secondly, a group
underwent neurotmesis of the buccal branch of the facial nerve with immediate, tension free
repair by epineurial suture and entubulation of the repair with a biodegradable glass tube
attached to an osmotic pump which delivered 2 ml of saline over a period of four weeks
(Group 2). Thirdly, a group underwent neurotmesis of the buccal branch of the facial nerve
with immediate, tension free repair by epineurial suture and entubulation of the repair with a
biodegradable glass tube attached to an osmotic pump which delivered 2 ml of neurotrophic
factors over a period of four weeks (Group 3). 50 pg of BDNF and GDNF and 100 pg of
CNTF were administered from the pump to this group. A mixture of factors, rather than three
separate groups was chosen to reduce the number of animals, and experiments, in line with
Home Office requirements (Animals (Scientific Procedures) Act, 1986). Because of the
solubility of the neurotrophic factors these doses were the maximum which could be
administered within a volume of 2 ml, the size of the osmotic pump. The groups of sheep are
shown in table 4.1. The null hypothesis was 'Neurotrophic factors delivered by this route
and in this concentration have no effect on nerve repair'.
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Group Number of sheep Procedure Purpose
1 6 N-N suture Control procedure
2 5 N-N suture with entubulation
and saline pump
Control procedure
3 6 N-N suture with entubulation
and neurotrophic pump
Neurotrophic experiment
Table 4.1. Ts -N = Nerve-to-nerve
Method of procedure
Anaesthesia
The sheep were transferred to the animal area one week before operation to allow the animals
to become accustomed to their environment. Operations were carried out under general
anaesthesia after a fast for solid foods of eighteen hours. Water was allowed up to the time of
operation. Induction to anaesthesia was achieved by an intravenous injection of a mixture of
etomidate and midazolam, (both 0.5 mg kg"1) into the left internal jugular vein. The animal's
trachea was intubated under direct vision with a cuffed endotracheal tube (Portex, Blueline)
after which the sheep was positioned on an operating table in the left lateral position. An ear
artery was cannulated and attached to an electronic blood pressure sensor. Venous access was
by means of a lateral saphenous vein cannula, which was used for administration of a single
dose of analgesic (flunixin, 2.2 mg kg"1 and buprenorphine, 10 pg kg"1). Prophylactic
cefuroxime (750 mg) was given intravenously immediately before surgery, in animals which
were to recover. Muscle relaxation was achieved by intravenous mivacurium (200 pg kg"1)
after induction of anaesthesia or after electromyography, if carried out. Intravenous
edrophonium (1 mg kg"1) was used to reverse relaxation if the animal was to recover.
Euthanasia was carried out by pentobarbitone (140 mg kg"1). In recovery cases, twice daily
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cefuroxime (750 mg) were administered by intramuscular injection for five days post¬
operatively.
Surgery
The animal's face was shaved with electric clippers on the left side. Recording electrodes were
placed with the cathode over the muscle belly of levator labii maxillaris, just above and lateral
to the mouth. The anode was placed over the nasal bones in the midline. The ground electrode
was place on a shaved area of the back. The buccal division of the facial nerve was stimulated
transcutaneously to map out the nerve. This made identification easier and less dissection was
needed to locate the nerve. For the recovery groups of sheep, the skin of the animal was
prepared with a povidone-iodine antiseptic solution (Betadine, Seton Health Care, England).
Sterile drapes were used to mask the area not within the operative field and sterile instruments
were used in the operation.
GROUP 1
An incision was made only over the identified buccal branch of the nerve. When this was
found, the nerve was cut by means of a Meyer neurotome and repaired with three or four 10/0
polyamide (Ethilon, Ethicon, UK) circumferential epineurial sutures using an operating
microscope (Wild, Heerbrugg M690). A tension-free repair was ensured. A 4/0 Vicryl
(Ethicon) suture was used to close the subcutaneous tissues. 4/0 Vicryl was also used to close
the skin by subcuticular suture with the knots buried to avoid the suture being removed by the
sheep. The closed incision was covered with an antiseptic vapour permeable dressing spray




Similarly to group 1, the buccal branch of the facial nerve was exposed and transected. Before
suturing, the nerve was threaded through a biodegradable glass tube (Giltech, Ayr, Scotland,
chapter 2). A tension free repair was ensured. The glass tube had a 1 mm central, drilled hole,
through which a silastic catheter had been glued. Beforehand, the tube and catheter had been
sterilised by gamma irradiation. The nerve was then sutured, as before, with epineurial nylon.
The middle of the glass tube was then positioned over site of the nerve repair. The glass tube
was sutured to the underlying fascia with 4/0 Vicryl and each end of the tube was plugged
with a small piece of muscle taken from an adjacent site. This muscle was held in place by
tissue glue (Tisseel, Immuno). Thus the glass tube ensheathed the nerve repair which was
relatively isolated from the surrounding tissue (figure 4.1). A miniature osmotic pump (Alzet,
Charles River, Kent) was filled with 2 ml of saline and the pump was connected to the plastic
catheter. A 3 x 5 cm pocket was created by tunnelling subcutaneously under the lower skin
flap into the neck and the pump, attached to the catheter, was placed in this pocket, in the
neck.
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The wound was then closed with a 4/0 Vicryl suture to the subcutaneous tissues and 4/0
Vicryl was also used to close the skin by subcuticular suture. The closed incision was covered
with an antiseptic spray (Nobecutane) and the animal was recovered from anaesthesia.
GROUP 3
This group underwent the same procedure as for group 2 except that a solution of
neurotrophic factors (BDNF, CNTF, GDNF) filled the osmotic pump. Osmotic pumps are
encased in a semipermeable membrane. Fluid moves by osmosis through the outer casing at a
constant rate. Within the outer casing, the contents of the pump are contained in a
compressible reservoir. Fluid diffuses through the casing, the reservoir is compressed and the
contents of the reservoir are released. The contents of the pump were therefore released into
the glass tube and around the nerve repair. The behaviour of recombinant proteins in vivo
makes it difficult to demonstrate accurately their activity in animal models. Many proteins
have extremely short half-lives of elimination in vivo. When administered by conventional
delivery methods, such as systemic injection, these compounds are rapidly eliminated,
resulting in wide variations in the level of recombinant protein in plasma and tissues. With the
use of an osmotic pump, tissue levels of neurotrophic factors are maintained and unwanted
side effects or systemic toxicity should be reduced because of protein delivery directly to the
site of intended action. This pump has been used widely in research and has proved reliable
(Mufson et al. 1996). Neurotrophic factors (BDNF, NT3 and NGF) have been shown to
maintain their stability in vivo in these pumps (Altar et al. 1994; Gu et al 1994; Mufson et al
1996).
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The animals were allowed to recover alone and observed by animal house staff until recovery
from anaesthesia was complete and the animal was self-caring. They were housed with other
animals and were monitored for signs of wound infection. The animals had little difficulty
establishing normal eating patterns. In groups 2, 3 and 4, approximately eight months after the
initial operation the animals were reoperated on, using the same techniques for general
anaesthesia. Single fibre electromyographic jitter was assessed through the skin (chapter 7).
The buccal branch of the facial nerve was identified by stimulation through the skin. The
buccal branch was dissected proximally just after the nerve exited from the parotid gland and
distally, near the angle of the mouth to expose the epineurium. Electrophysiological studies
were carried out (chapter 7). A few millimetres of the buccal branch were then excised and
processed for histological examination (chapter 6). The contralateral buccal branch of the










The application of statistical tests to data which have been derived from experimentation, is a
means of simplifying large amounts of information. Without statistics, conclusions could often
not be drawn from the data, or worse, inappropriate conclusions may be drawn which, without
detailed analysis of the data may appear correct. There are two fundamentally different groups
of statistical tests, parametric and non-parametric. Parametric tests involve the manipulation
of quantitative data. Before parametric analysis can be carried out however, it should be
shown that the data are normally distributed. Non-parametric tests involve placing variables in
order of rank and thus some sensitivity is lost when using non-parametric statistics. For this
reason, in the present work, parametric statistics were used whenever possible. Statistical
testing was carried out using a computer and a statistical software package (Statistica,
Statsoft, USA). A p-value of less than or equal to 0.05 was considered significant and the null
hypothesis was rejected. The null hypothesis for this work was 'neurotrophicfactors have no
influence on regeneration ofthefacial nerve after division and repair\
The Normal Distribution
The Normal Distribution also known as the Gaussian Distribution is the fundamental
distribution of probability in statistics. The word 'normal' in this context means 'conforming
to a rule or pattern'. This distribution is symmetrical, with values more concentrated in the
middle than in the tails, sometimes described as 'bell shaped'. The standard deviation of the
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distribution shows the spread of data about the mean, and tends to be smaller for larger
samples and larger for smaller samples. When the data in the set are not normally distributed,
they may be converted to a normal distribution by the use of transformations (e.g. logarithmic
or exponential).
The Half-Normal Plot
The half-normal plot was constructed by finding the mean of a measured set of variables. The
residuals of each variable were found by subtracting the mean of all variables from each
measured value of that variable. The sign of the residual (+ or -) was ignored. These residuals
were then placed in order of rank. From these ranks the Z value was computed (i.e.
standardised values of the normal distribution) based on the assumption that the data came
from a normal distribution. These Z values were plotted on the y axis in the plot. If the
observed residuals (plotted on the x axis) were normally distributed, then all values should
have fallen onto a straight line. If the residuals were not normally distributed, then they would
deviate from the line. Outliers became evident in this plot. When outliers were identified these
were excluded from further statistical analysis.
The Kolmogorov-Smirnov plot
In this work, all data were tested for normality by plotting frequency distribution histograms
and testing by the one-sample Kolmogorov-Smirnov categorised test. This statistical method
plots the data as a histogram and constructs the graph of the equation of a normal distribution
with the same mean and variance as this data. A one-tailed Kolmogorov-Smirnov test is then
done to determine if there is a difference between the data and the calculated equation of the
normal distribution. If the Kolmogorov-Smirnov test indicated statistical significance, the
hypothesis that the observed data followed the normal distribution was rejected. If the
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Kolmogorov-Smirnov test yielded a result which was not statistically significant, it was
accepted that the data were normally distributed.
Statistical tests
The F test
The F test was carried out on all data which had been shown to be normally distributed. This
test is a test of variance which can be applied to different groups simultaneously. A significant
result from the F test does not indicate which of the groups is likely to come from a different
population. In order to identify which of the groups differed from the others, the two-sample t
test was used to detect differences between groups. The advantage of the F test is that only
one test is required for all groups. If multiple t tests were carried out (accepting a significant
result at p<0.05) then there would be a probability that 1 in 20 tests would yield a significant
result. Multiple t testing therefore carries an increased risk of a type I error, when the null
hypothesis is wrongly rejected. In this work, where the null hypothesis for the F test was
accepted, t tests were not carried out.
The two-sided Student's t test.
The t-test is the most commonly used method to evaluate the differences in means between two
groups. The groups can be independent (e.g., nerve conduction in animals that were
administered neurotrophic factors compared to a control group that received a placebo) or
dependent (e.g., fibre diameter in animals before compared to after nerve division and repair).
The t-test can be used even if the sample sizes are very small as long as the data has been
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Anatomy of the peripheral nerve
Erlanger and Gasser described the classification of peripheral nerves (A, B and C) according
to conduction velocity, by three peaks identified on a compound action potential, recorded
from a mixed nerve (table 6.1) (Erlanger & Gasser 1937). It is also known that there is a
direct, proportional relationship, in a myelinated fibre, between fibre diameter and conduction
velocity (Rushton 1951). Group A fibres are the largest, fastest conducting fibres. Group B
are myelinated autonomic and preganglionic fibres. Group C are the smallest and slowest
conducting unmyelinated fibres which function as somatic afferent fibres and postganglionic
autonomic efferents. Group A can be subdivided into four groups by size. Aa are motor
fibres. A// are associated with touch sensation, Ay are motor to muscle spindles and AS are
associated with sharp pain and temperature sensation (Lundborg 1988).
Fibre type Function Axon
diameter
(pm)
Myelinated / unmyelinated Conduction
velocity, ms'1
Aa (I) motor a - fibres 9-18 myelinated 70-120
spindle afferents (la)
tendon organs (lb)
A/? (II) touch and pressure 5-12 Myelinated 30-75
Ay (II) motor to muscle spindles 3-6 Myelinated 18-36
AS (HI) pain, pressure,
temperature
1-5 Unmyelinated 4-30
B (III) Preganglionic 3 Unmyelinated 3-12
C (TV) pain, touch, heat 1 Unmyelinated 1-2
Table 6.1. Classification of nerve fibres
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The peripheral nerve is a composite of tissues which not only acts as a conduit for electrical
conduction but also provides nutrition, protection and electrochemical insulation. Nerve fibres
are closely packed in endoneurial connective tissue in fascicles or 'funiculi'. A perineurium
surrounds these fascicles and these are in turn surrounded by an epineurium
In a motor nerve all motor fibres are myelinated. The myelin sheath of the axon is the cell
membrane of the Schwann cell which becomes wrapped around the axon multiple times, in a
spiral with no intervening cytoplasm to separate the layers. This produces alternating layers of
lipid and protein. It is here that exists the fundamental difference between myelinated and
unmyelinated fibres. Unmyelinated fibres still possess Schwann cells. In unmyelinated fibres
however, many axons invaginate a single Schwann cell and the Schwann cell membrane does
not spiral around the axons. In myelinated fibres one Schwann cells surrounds only one axon
longitudinally and at junctions between Schwann cells, this covering is deficient (nodes of
Ranvier).
The axon has a core of cytoplasm (axoplasm) surrounded by a plasma membrane (axolemma).
The axolemma is bound to the myelin sheath of the Schwann cell and to the Schwann cell's
basal lamina, which together with the reticular lamina forms the basement membrane. The
'endoneurial tube' or 'endoneurial sheath' (Millesi & Terzis 1984) consists of this basement
membrane and the endoneurial reticular and collagen fibres providing the framework
supporting the nerve fibre.
The endoneurium is a loose collagenous matrix with large extracellular spaces. The matrix
contains Schwann cells, endothelial cells, fibroblasts, mast cells and capillaries. The
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endoneurial space thus allows diffusion of substances rapidly along the length of the nerve
(Selander& Sjostrand 1978).
The perineurium surrounds the endoneurial space, isolating it by its strength and density and
protecting the contents of the space (the axons) from mechanical trauma and chemical changes
(Thomas & Olsson 1984). The mechanical strength of the perineurium is impressive. The
intrafascicular pressure can be increased to 750 mmHg before rupture of the perineurium
(Selander & Sjostrand 1978). The perineurium consists of a number of lamellae, of
epithelium-like, flattened cells. These cells possess basement membranes on their outer and
inner surfaces (Thomas & Olsson 1984). The number of lamellae vary with the diameter of
the fascicle. In the mammalian nerve up to 15 lamellae may be present. The cells of the
perineurium are joined by tight junctions, thus acting as a diffusion barrier. The lamellae of
the perineurium contain capillaries within longitudinally and obliquely orientated collagen and
elastic fibres. The perineurium is pierced by blood vessels throughout its length, taking with
them a sleeve of perineurium. More importantly, the perineurium is deficient distally, near the
motor end plate. This may be an important route for entry of substances, which could
otherwise not penetrate the perineurium, into the endoneurial space.
It has been shown in many studies that the perineurium acts as a diffusion barrier e.g. to
small-molecules proteins (Olsson & Reese 1969), ferritin (Waggener et al 1965) and
exogenous proteins (Lundborg & Rydevik 1973). Perineural cells also show high activity of
dephosphorylating and oxidative enzymes and this suggests that they are metabolically active.
The perineurium is thought to play an important role in the regulation and maintenance of the
'internal milieu' of the endoneurial space. Nerves can maintain their function when surrounded
by a pyogenic focus and this is probably due to the perineurium. This is perhaps best seen in
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acute otitis media, where facial nerve function is invariably retained, despite the incidence of
facial nerve dehiscence in the middle ear being as high as 56 or 60 % (Perez et al 1997;
Moreano et al. 1994).
The epineurium is a loose, but strong, connective tissue which embeds and protects nerve
fascicles. Epineurium is more abundant near joints where greater protection of fascicles is
required. The epineurium contains a well developed vascular plexus with longitudinal vascular
channels feeding endoneurial capillary plexuses. Deeper layers of epineurium separate
fascicles while also keeping them loosely together. The connective tissue of the epineurium is
condensed superficially to form an adventitia.
Fixation of nerve
Specimens of nerve tissue were processed by a standard method (Gschmeissner et al 1990)
with minor modifications. This produced resin imbedded sections which were then cut using a
microtome.
After the nerve had been removed from the animal the surrounding tissue and fat were
trimmed grossly. The nerve specimen was placed on a piece of card and immersed in 2.5%
gluteraldehyde in 0.1M sodium cacodylate buffer at room temperature for between one and
two hours. The specimen was then removed from the solution, placed on dental wax and
viewed, at 25 times magnification, under a binocular, dissecting microscope (Wild,
Heerbrugg). The cut ends of the nerve were irregular, and these were trimmed using a razor
blade. The initial fixation increased the resistance of the tissue and enabled the nerve to be
sectioned transversely, in 0.5 - 1 mm slices, resulting in smooth cylinders of tissue. These cut
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cylinders of nerve were again placed in 2.5% gluteraldehyde in 0.1M sodium cocodylate
buffer and left overnight in a tissue agitator (Rolamix, Bio-rad). The sections were then
washed three times, each for 20 minutes, in 5% sucrose buffer. The tissue was then incubated
in 1% cacodylate buffered osmium tetroxide at room temperature for three hours. Osmium
preserves myelin and is essential for the identification of the myelin sheath of the nerve. The
specimens were then washed three times, each time for 20 minutes in 10% alcohol and then
washed three times, each time for 30 minutes in 100% alcohol. The tissue was then washed in
propylene oxide for 30 minutes and embedded in Araldite overnight at room temperature. The
sections were then removed from the Araldite which was not yet polymerised and reimbedded
in fresh Araldite using the dissecting microscope to orientate the cylinders of nerve so that
transverse section could be cut easily. The tissue was placed in an oven at 60 °C for 72 hours
which allowed polymerisation of the Araldite to a hard mould.
Cutting of nerve sections
The fixed sections of nerve, once imbedded in Araldite, could be kept indefinitely and semi-
thin sections (1 pm) were made at a convenient time. The Araldite mould with the section of
nerve to be cut was mounted on a wooden dowel and a ultramicrotome (C. Reichert OMU3).
A freshly cut glass knife was used to cut the sections. The sections were lifted by a needle and
mounted on a glass slide over which a drop of chloroform was suspended to evaporate some
Araldite. The slides were then dried on a hot plate.
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Staining ofnerve section
Two stains were used for nerve sections. First, toluidine blue and pyronin B stains all tissue
structures to a varying degree and was used to check orientation and preservation of the block
during sectioning (Figures 6.1 and 6.2).
Figure 6.1. Toluidine blue and pyronin B stain of a normal buccal division of the facial nerve
in the rat.
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Figure 6.2. Toluidine blue and pyronin B stain ofa normal buccal division of the facial nerve
in the rat, high power view of figure 5.2.
Second, paraphenylenediamine is a specific stain for osmiophilic material and would thus
preferentially stain the myelin sheath of nerve fibres (Figures 6.3 and 6.4).
Paraphenylenediamine was used to advantage in that the nerve fibre could be clearly defined
from surrounding tissue and computer recognition of axons was used in a commercial image
recognition package (Analytical Imaging Station (AIS) version 3.0, Imaging Research Inc,
Canada). 1% toluidine blue in 1% sodium tetraborate was dropped over the slide while the
slide was still warm. When steam was seen to rise from the slide the stain was washed with
cold water, taking care not to let the stream of water touch the tissue. For staining with
paraphenylenediamine, slides bearing nerve sections were placed in a Coplin jar with a freshly
filtered solution of 1% parapheneylinediamine for 1 hour. These were then washed with
distilled water and 96% alcohol.
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Figure 6.3. P-phenelenediamine stain of a normal buccal division of the facial nerve in the rat.
Figure 6 .4. P-phenelenediamine stain of a normal buccal division of the facial nerve in the rat,
high power view of figure 5.4.
Assessment of nerve morphometry
After neurotmesis and nerve repair, the recovery of function of a nerve depends on several
variables which include: the number of fibres reaching the target organ, the maturation of the
fibres, the speed with which the fibres reach the target organ and the appropriateness of the
57
connections made within the target organ. Many authors have concentrated on morphological
measurements of the regenerated nerve. These have included:
Nerve fibre counts (Glasby et al. 1986b; Glasby et al. 1986a)
Axon diameter (Glasby et al 1990)
Fibre diameter (Glasby et al 1990)
Myelin sheath thickness (Glasby et al 1986b; Glasby et al. 1986d)
G-ratio (Guntinas-Lichius et al. 2000)
NERVE FIBRE COUNTS
After neurotmesis, the regenerating axon produces up to twenty neurites, explaining the large
increase in the number of fibres found in regenerating nerves (Bray & Aguayo 1974). If these
neurites fail to establish peripheral, end organ connections these neurites die and the total
number of fibres decreases with time (Aitken et al 1947). Absolute fibre counts may therefore
be misleading, not representing the final state of nerve morphology although neurotrophic
factors can cause an increase in neurite sprouting after nerve transection (see chapter 1).
Measurements of nerve fibre counts can be absolute (where all fibres are counted in the nerve)
or derived (where the number of fibres in one area is counted and the total number of fibres
calculated by scaling up to the total area of the nerve (Mayhew 1992)).
MEASUREMENT OF FIBRE DIAMETER
With time, after repair of a peripheral nerve, maturation of nerve fibres takes place and fibre
diameter increases as smaller fibres, which fail to make peripheral connections, die. The
eventual size of regenerating nerve fibres is dependant to some degree on the diameter of the
parent fibre but mainly on whether contact is made with an appropriate end organ (Aitken &
Thomas 1962; Bray & Aguayo 1974). Fibres which fail to make appropriate end organ
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connections may become myelinated but may fail to reach normal size (Sanders & Young
1947). Fibre diameters were measured across the minor axes of elliptical profiles (Mayhew
1990) to avoid bias arising from sections cut obliquely. Mayhew suggested that at least 200
fibres should be counted to give a representative sample of the whole nerve (Mayhew 1990).
MYELIN SHEATH THICKNESS
In regenerating nerves the myelination of smaller fibres is less than in larger fibres. Myelin
sheath thickness is therefore different from regenerating nerves and normal nerves. A better
variable to measure is the g-ratio (axon diameter / fibre diameter). The g-ratio is an indicator
of nerve fibre maturation (Glasby et al 1986a).
Microscopy
NEURONE COUNTS
To count the total number of neurones in a nerve it was decided to count the absolute number
of fibres. This has the advantage of accuracy, in that no calculations are required to derive the
total number of fibres, as in the scaling technique as described by Mayhew (Mayhew 1992).
In order to identify single neurones, and thus allow a count of the total number of neurones in
a nerve section, it was necessary to obtain an image using a 40 times magnifying lens. An
image of lesser magnification failed to differentiate between small and closely spaced
neurones. The resulting 40 times magnification image only encompassed a fraction of the total
nerve section. Moving the microscope platform and counting sequential high power fields was
prone to error by counting fibres twice, or not at all. A novel technique was devised where the
nerve section was digitised by a camera attached to a microscope and stored on computer as a
TIFF file (Tagged Image File Format). TIFF is a compressed and highly flexible, platform-
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independent format which is supported by numerous image processing applications. The nerve
section could be reconstructed from multiple TIFF images (at 40 times magnification). Each
TIFF file was 'copied' and 'pasted' into a blank TIFF file in an image manipulation computer
software package (Photoshop 5, Adobe, USA). Thus an image of the whole nerve was built up
from between two and forty TIFF images (figure 6.5). This final image was saved on
computer hard disc and loaded into an image analysis computer software package (Analytical
Imaging Station (AIS) version 3.0, Imaging Research Inc, Canada). With the AIS software,
each neurone on the reconstructed image was marked using a mechanical pointing device
('mouse'). The program automatically recorded the number ofmarks made over the image and
thus the number of neurones in each nerve section was calculated.
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Figure 6.5. A TIFF file reconstructed from four high power images to show the entire nerve
section.
This technique for counting nerve fibres was used in the rat facial nerve where the nerve
section was small enough to enable the whole fibre to be reconstructed. In the sheep facial
nerve, the nerve fibre was too large to allow reconstruction by this method. Also, in the sheep
nerve, fixation of the sections was unreliable owing to their large size and not all fibres could
readily be identified. In the rat, the repaired nerves (which tended to be larger than normal)
were still small enough for their images to be reconstructed. Fixation of the smaller, rat nerve
was also superior to the sheep facial nerve due to better penetration of fixative. In the rat,
fibre counts were made on the nerve section removed at division and again on the nerve three
months after repair. Thus it was possible to calculate a ratio of number of fibres after division
and repair to number of fibres before division and repair (fibre ratio):
61
Fibre ratio = number of fibres after division and repair
number of fibres before division and repair





In addition to these measurements, fibre ratio was calculated in the rat experiments.
MEASUREMENTS OF SIZE
Nerve sections were viewed under 100 times magnification using an oil immersion technique.
The dry side containing the semi-thin section of nerve embedded in araldite was placed on a
microscope platform (Jenamed Variant, Carl Zeiss) and a drop of oil was placed over the
section. No cover slip was used, resulting in a more focused image than if a cover slip was
used. A beam splitter was used with the microscope, which allowed binocular vision of the
section with 10 times magnifying eyepieces resulting in a effective magnification of 1000
times, and a camera (Kestril 25) image to be displayed. This camera image was input directly
to a commercial image analysis computer software package (Analytical Imaging Station (AIS)
version 3.0, Imaging Research Inc, Canada). Several images (figure 6.6) of the centre of the
largest fasicle of each nerve were obtained and stored on hard disc as a TIFF fde.
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Figure 6.6. High power oil immersion digital image of a nerve section.
After images of all nerve sections had been digitised in this way they were later analysed by
the image analysis program. This system required calibration, and the image of a 2mm
graticule with 10pm divisions was similarly digitised using oil immersion microscopy. The
computer program recorded this calibration and this was used for all measurements to be
obtained. Measurement of the axon and fibre diameters were obtained on 300 neurones of
each nerve section. Fibre diameters were measured across the minor axes of elliptical profiles
to avoid bias arising from sections cut obliquely. The myelin sheath thickness was calculated
by the formula:
Myelin sheath thickness (pm) = Fibre diameter (nm) - Axon diameter turn)
2
The g-ratio was calculated by the formula:
G-ratio = Axon diameter (urn)
Fibre diameter (pm)
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Although electrical stimulation of nerve and muscle, as an aid to clinical diagnosis, has been
used for more than one hundred years it has only been since the Second World War that these
techniques achieved widespread use. Electrophysiology cannot replace the skill of clinical
neurological examination, it can, however, provide more objective information on the function
of the motor unit and sensory nerves. Electrophysiology can also be used in an animal model
where clinical examination is unreliable and voluntary movement is unpredictable. The motor
unit is an 'individual nerve cell and the bundle of muscle fibres it activates' (Sherrington
1929) and consists of the nerve cell, nerve fibre and its terminal branches, neuromuscular
junction and the muscle fibres and constituent myofibrils. Each motor neurone innervates from
less than twenty to more than one thousand muscle fibres, depending on how much fine motor
control is required. A normal muscle fibre is innervated by only one neurone.
The mammalian peripheral nerve
Within the mammalian nerve cell there exists a very different microenvironment from that of
the extracellular fluid. Within the cell there is an abundance of potassium ions and a dearth of
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sodium ions. These cations together with anions maintain the osmolarity of the cell, however
an electrical gradient exits, with the cell being negative relative to the extracellular fluid. This
membrane potential is approximately -90 mV inside the axon and -70 mV inside the cell soma.
An action potential is generated when the potential difference across the cell membrane
reaches approximately -65 mV (that is, when the cell is depolarised to the threshold level). In
normal function this occurs owing to influence by other neurones or end organs.
Experimentally it can be induced by electrical stimulation of the axon. In a myelinated nerve,
layers of phospholipid membrane from the ensheathing Schwann cell insulates the axon. This
layer is deficient at the node of Ranvier, where current can flow between intracellular and
extracellular fluid. The application of a cathode to the nerve causes an accumulation of
positive charges in the axon at this point. This depolarises the axon and when threshold is
reached an action potential is generated, involving a complex series of ionic permeability
changes in the cell membrane and the axon at this point becomes momentarily positively
charged. In the cell, current flows from the depolarised area to the negatively charged areas
both proximally and distally to the site of stimulation. An opposing current flows in the
opposite direction through the extracellular fluid. With this flow of current bidirectionally,
from the point of stimulation, the nodes of Ranvier on either side become depolarised and two
action potentials are generated, one travelling orthodromically, the other travelling
antidromically (figure 7.1). This 'saltatory' conduction propagates rapidly as current jumps
from one node of Ranvier to the next. In a motor neurone, stimulated artificially in this way,





1. Cathodal stimulation causes a positive charge in the axon and depolarisation
2. Action potential generated with large positive charge generated
3. Current spread to nodes of ranvier at each side
4. Further depolarisation at next node and cycle repeats with AP propagation
Figure 7.1 Saltatory conduction
Refractory period
For a short time (0.5 - 1 ms) after the initiation of an action potential in a neurone, the cell
becomes unable to generate a further action potential regardless of the intensity of the stimulus
delivered. This is the absolute refractory period. The cell then gradually recovers to be
excitable only by a stimulus which is larger than that which would normally be required to
generate an action potential. This period of reduced excitability is the relative refractory
period (usually 3-5 ms). Underlying the refractory period is the inability of sodium channels
in the cell membrane to respond immediately to repeated stimulation. The clinical value of
refractory period measurement is uncertain (Kimura 1981). The refractory period is however,
prolonged in low temperature (Paintal 1965), advanced age (Delbeke et al 1978) and after
experimental demyelination (Smith & Hall 1980).
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The neuromuscular junction
The neuromuscular junction is a synaptic structure consisting of the motor nerve terminal,
junctional cleft and the muscle end plate. Within the motor nerve terminal, vesicles of
acetylcholine are stored and released by a calcium-dependant depolarisation of the neurone.
The acetylcholine released by the nerve terminal acts upon the motor end plate of the muscle
cell to increase membrane permeability, mainly to sodium and potassium ions. As in nerve
cells, potassium has a high, and sodium has a low intracellular concentration in muscle. This
increase in membrane permeability results in sodium and potassium flux and depolarisation of
the motor end plate. Again, as with neural tissue, if this depolarisation reaches a certain level
(threshold) an action potential is generated. This propagates bidirectionally along the muscle
fibre. There is therefore a delay in the activation of a muscle action potential by a nerve action
potential, the neuromuscular delay. This represents the time taken for the release of
acetylcholine, its time to cross the neuromuscular gap and trigger the ionic changes in
membrane permeability.
The summated muscle action potential may be recorded by electrodes placed over the surface
of the muscle, either directly or through skin. The cathode (negative electrode) is positioned
over the muscle belly and the anode (positive electrode) over the muscle tendon with a
galvanometer between the two electrodes. Initially there is no potential difference between the
electrodes (figure 7.2a), with the muscle fibre being equally negative under both electrodes.
On an oscilloscope, the trace is flat. When depolarisation of the muscle occurs, the cell
becomes momentarily positively charged and this results in a negative deflection (by
convention, upward) on the oscilloscope (figure 7.2b). When the action potential impulse
reaches the midpoint of the electrodes there is again no potential difference between electrodes
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and the trace crosses the baseline (figure 7.2c). When the action potential impulse reaches the
anode a positive deflection occurs resulting (by convention) in a downward trace (figure 7.2d).
The trace then returns to the baseline at the end of the action potential (figure 7.2e). The trace
obtained from the muscle action potential is called the 'm-wave' or 'cMAP' (compound
muscle action potential). The m-wave obtained in this way is biphasic.
Electrophysiology is an integral and routine part of neurological investigation. Nerve
conduction studies are reliable for accurate characterisation of peripheral nerve function
(Kimura 1989). These studies have been used clinically and experimentally (Fullarton &
Glasby 1997; Glasby et al 1997; Glasby et al 1988) to assess nerve regeneration and repair.
68
An action potential (|)
originates in the muscle
A negative potential
is recorded as the AP
reaches the first electrode
There is no potential
difference between
electrodes
The AP reaches the
second electrode and a
deflection arises
The AP passes the second
electrode and no potential
difference exists between
the electrodes again
Figure 7.2 A muscle compound action potential
Measurement of conduction velocity
In 1944, Berry et al showed that the conduction velocity in a regenerating nerve fibre was
slowed (Berry et al 1944). Since then this test has been used extensively in a clinical setting. It
is not possible to calculate nerve conduction velocity by stimulating a nerve, a known distance
from the muscle and recording a contraction after a measured time interval, because this time
interval for muscle contraction consists of not only of the time taken for the impulse to travel
along the nerve but also of the neuromuscular delay. To eliminate the neuromuscular delay,
two points on the nerve are stimulated independently (SI and S2 in figure 7.3). The time for
muscle contraction is recorded from both points and the difference between the time to trigger
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muscle contractions is known as the interstimulus interval. The maximum conduction velocity




Where CVmax = maximum conduction velocity (ms1)
d = distance between stimulating electrodes (mm)
t = interstimulus interval (ms)
As there is a range of conduction velocities in a nerve this only represents the fastest fibres
which will first trigger a muscle contraction.
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Measurement of refractory period
Measurement of refractory period has been investigated in experimental animals and in
clinical practice. The 'paired shock technique' is used to stimulate a nerve at one point and
apply a second stimulus after a time interval, t (figure 7.4). At the end of the absolute
refractory period a small additional trace is seen on the first m-wave. This can be better
identified by digital subtraction of the m-wave obtained from the first single stimulus. At the
end of the relative refractory period a further m-wave, identical to the first is seen, and again
by the use of digital subtraction of the initial wave this second m-wave is more easily
identified. In figure 7.4, t\ represents the end of the absolute refractory period and /2
represents the end of the relative refractory period.
Figure 7.4 The paired shock technique to assess refractory period
Measurement ofminimum conduction velocity
The measurement of conduction velocity above, only identifies the fastest nerve fibres. Using
the technique of 'collision' (Thomas et al 1959) the velocity of the slowest conducting fibres
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can be obtained. With this technique two points on the nerve are stimulated supramaximally
(SI and S2 on figure 7.5). When both stimuli occur together impulses travel orthodromically
from SI to the muscle producing a compound action potential. Impulses also travel from SI
antidromically towards S2. Impulses from S2 travel orthodromically and collide with the
distal impulses cancelling each other out. No compound action potential is thus produced from
the S2 stimulus (figure 7.5a). If SI and S2 are separated by a time interval the antidromic
impulses from SI will travel towards S2 before the S2 stimulus is triggered. If the time
interval is just long enough for impulses in the fastest conducting fibres to pass the point S2
before a stimulus occurs, these fastest conducting fibres will escape collision. The slower
conducting fibres will still collide when the S2 stimulus is triggered and cancel each other out
(figure 7.5b). Thus a second compound action potential is recorded from only the fastest
conducting fibres. As with the technique of recording refractory period this can be better
identified by digital subtraction of the m-wave obtained from the first stimulus. If the time
interval between SI and S2 is just long enough for the slowest conducting fibres to pass the
S2 point before a stimulus occurs all fibres will escape collision and a second full compound
action potential will be recorded (figure 7.5c). If the distance, d between electrodes, and the
interstimulus interval which just produces a full second compound action potential, t2 are




where CVmin = minimum conduction velocity (ms"1)
d = distance between electrodes (mm)










A cMAP is generated from stimulus, S1




b) SI then S2 after time, t\
collision 1 slow fibres
) fast fibres
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A cMAP is generated from S1 and a second
cMAP is generated from impulses in the fast fibres
from S2. Impulses from the slow fibres, stimulated
by S2 collide with impulses from the slow fibres
stimulated by S1. Thus, impulses from the slow fibres
stimulated by S2 do not contribute to the second
cMAP
c) S1 then S2 after time, t2
A cMAP from S1 and a second AP of equal
size from S2 is generated from impulses from






Figure 7.5 Technique of collision to calculate speed of the slowest conducting fibres
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Electromyographic jitter
Single fibre electromyography (SFEMG) was developed (Stalberg & Trontelj 1979) to assess
the microphysiology of the motor unit — terminal axon, neuromuscular junction and muscle
fibre. Stimulated jitter, an SFEMG technique, is a means of measuring the variation in
transmission at the neuromuscular junction. It involves the stimulating of a terminal motor
axon and the recording of an associated muscle fibre's action potential.
Stimulating a nerve fibre repetitively results in almost, but not exactly the same latencies of a
muscle fibre action potential (figure 7.6). This variability, in the order of tens of microseconds
represents electromyographic jitter. It has been shown that there is normally little variability in
the transmission of the impulse in the axon (Stalberg & Trontelj 1979; Trontelj et al. 1986) or
muscle fibre (Trontelj et al 1990) during the jitter analysis. It is postulated therefore that the
site of variability in neuromuscular transmission is at the end plate.
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Stimuli x 2, after
time interval
F igure 7.6 Electomyographic j itter
Transection of a peripheral motor nerve results in Wallerian degeneration of the distal nerve
and degeneration of the neuromuscular junction. With a surgical repair, proximal axons grow
to re-establish a neuromuscular junction. In the immature motor unit there is a large
variability in the time for neuromuscular transmission due to lower and more variable
threshold potentials at the motor end plate (Stalberg 1990; Stalberg & Trontelj 1979). As
maturation of the motor end plate continues threshold potentials rise and stabilise. It has been
shown in rats, that jitter values after transection and repair of a peripheral motor nerve were
highest in the early stages after repair and declined to normal within 90 days of repair
(Lenihan et al. 1997). SFEMG jitter may thus offer a means of assessment of the quality of
nerve repair by assessing the state of the neuromuscular junction, which nerve conduction
studies and assessment of refractory periods cannot do. SFEMG techniques such as jitter offer
a more specific assessment ofmuscle action potentials. The SFEMG active electrode is a steel
needle 0.5 mm in diameter with an insulated silver wire in its lumen. A 25 pm opening 3 mm
from the tip of the needle contains the active electrode. This small area for recording increases
the probability that the action potentials recorded will be from the same motor unit. Filtering
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offers another method of increasing the selectivity of the recorded action potentials. Since
muscles act as a low pass filter, they will remove high frequency signals originating from
more distant muscle fibres. Thus, recordings from fibres situated near the active electrode will
contain a relatively higher proportion of high frequency components. If the filter on the EMG
amplifier is set at 500 Hz, impulses from distant muscle fibres will be removed while affecting
muscle fibres adjacent to the active electrode only by a factor of 10% (Stalberg & Trontelj
1979). Parameters for jitter recordings have been defined. The stimulating pulse should be of
50 ps duration and of amplitude between 1 mA and 25 mA. The recorded amplitude should be
>0.5 mA, with a rise time of<200 ps and a duration of 1-2 ms.
The latency between the stimulating pulse and the muscle fibre action potential is called the
inter-potential interval (IPI). Each axon is stimulated at least 50 times and the IPI for each
action potential is recorded. The jitter from the end plate which produces the action potential
is calculated as the mean consecutive difference of the latencies (MCD) using:





MCD = mean consecutive differences (ps)
ipi = inter-potential interval
n = number of stimulations
Previous work has shown that for a jitter study to be meaningful, a population of at least 20
muscle fibres pairs should be assessed. The MCD for each recording is thus calculated and
the mean of these values is the jitter value for that muscle. If the muscle was stimulated
MCD = Y
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directly, as evidenced by a jitter value of<5 ps (Stalberg et al 1992; Trontelj et al 1990), or if
an adjacent motor axon was inadvertently stimulated to produce summation with the action
potential under study, that reading was discarded.
Methods
Electrophysiological testing of the facial nerve in the sheep was carried out under general
anaesthesia as described in chapter 4. The face of the animal was shaved with electric clippers
from the midline over the nasal bones, under the eye and over the nose to the corner of the
mouth. The skin of the sheep was then cleaned with chlorhexidine. A ground electrode was
placed on the skin over the nasal bone.
Electromyographic jitter was recorded from the depressor labii maxillaris muscle. All
recordings were made by a Medelec Sapphire 4 ME electrophysiology recorder. Two
monopolar needles (Medelec MF37) were used as the stimulating anode and cathode. The
cathode was inserted into the muscle midway between the external nares and the angle of the
mouth. The anode was placed 0.5 cm rostral to the cathode. Stimulus pulses of 10 Hz
frequency, 50 ps duration and 1 mA amplitude were used initially. The current was increased
gradually until small twitches were observed in depressor labii maxillaris. At this stage an
SFEMG needle recording electrode (Medelec SF25) was inserted into the muscle 2 cm caudal
to the stimulating cathode. The position of the SFEMG needle electrode was adjusted until
satisfactory recordings ofmuscle action potentials could be seen. The current was increased to
10% above maximum. The maximum current was defined as current at which no further
increase in the amplitude of the m-wave would result from a further increase in the current. 20
values of jitter was then assessed as above. After each five recordings of jitter, the recording
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needle electrode was moved by a few millimetres to assess another population of muscle
fibres.
In animals which had undergone surgical repair of the nerve, the original incision was
reopened and the buccal division of the facial nerve identified. The buccal division of the nerve
was then dissected free from associated tissue as in chapter 4. As long a length as possible
was exposed. The portion of the nerve surrounded by the parotid gland was not dissected.
Previous experience had shown that if parotid secretions were allowed to come into contact
with the nerve it would fail to stimulate electrically. The buccal division of the nerve was
dissected from just distal to the parotid gland to the corner of the mouth. All stimulations and
recordings were carried out using a Medelec Sapphire 4ME EMG recorder (Medelec, Old
Woking, UK).
A 6 mm silver / silver chloride recording electrode (cathode) was placed over the motor point
of the depressor labii maxillaris. A second 6 mm silver / silver chloride disc recording
electrode (reference anode) was placed on the skin 1 cm superior to the insertion of the levator
nasolabialis muscle over the nasal bone. A small amount of electrode cream (Grass
Instruments Co., Maine, USA) was placed on each electrode to improve both electrode
adhesion and m-wave recording.
A non-traumatic bipolar platinum wire stimulating electrode (Si) was place on the buccal
division of the facial nerve distal to the site of nerve repair, approximately 5 mm proximal to
the zygomaticus muscle. A square wave of 50 ps duration of supra-maximal current intensity
(30% above maximum stimulation) was then delivered to the nerve. The resulting m-wave
recorded from depressor labii maxillaris was digitally filtered and amplified before being
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displayed on the EMG recorder screen. The change in voltage from the isoelectric baseline to
the peak (point of inflection) of the m-wave was taken as the m-wave amplitude. Where two or
more peaks were present in the negative (upward) phase of the m-wave, the amplitude was
taken as the distance from the baseline to the largest peak. Clinical electrophysiology
conventions were followed so that the area of the m-wave was defined as the area of the
negative phase of the m-wave.
A second bipolar stimulating electrode (S2) was placed on the facial nerve proximal to the site
of repair ensuring that the distance between both stimulating electrodes was greater than 5 cm.
The nerve was then stimulated with the same intensity as above.
The above methods were then used to obtain the following four variables:
1. maximum conduction velocity
2. minimum conduction velocity
3. absolute refractory period
4. relative refractory period.
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Chapter 8








There is no ideal animal model for the study of the facial nerve. Models used extensively
include the cat (McGuirt & McCabe 1977; Yamamoto & Fisch 1975), rabbit (Spector et al.
1993) and sheep (Drew et al. 1995; Glasby et al 1995; Glasby et al 1993). While large
animals may be more relevant to human neurosurgery, their cost can prohibit their use. If it is
feasible to carry out studies on large animals, these must entail small numbers of animals
(because of cost and legal requirements) and large animals are more prone to anaesthetic
difficulties. Novel techniques of nerve repair, grafting and the use of neurotrophic factors
must first be piloted on smaller laboratory animals to test the effectiveness of these techniques.
The rat is a commonly used laboratory animal and within the financial resources of even small
studies. The rat has been described as an excellent model for surgical experimentation on the
facial nerve (Mattox & Felix 1987; Murray 1991). These studies have not however, been able
to use electrophysiology in the assessment of the rat facial nerve, but have relied on
morphometric analysis of the nerve. Electrophysiology is not only the gold standard in the
assessment of nerve function, but is also the test used in the human when evaluating this
function.
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In the rat, the length of the facial nerve from the stylomastoid foramen to its distal branches is
only 3 cm at most. It is therefore not possible to carry out nerve conduction testing with
proximal and distal stimulating electrodes. The new generation of EMG recorders, however,
are sensitive enough to allow meaningful and consistent recording from stimulating the rat
facial nerve by a single electrode. In the present study, a model for the electrophysiological
assessment of the rat facial nerve, was developed, similar to the clinical assessment of the
facial nerve in humans, popularised by Fisch (Gantz et al. 1984). This technique will enable
research to progress in nerve repair using this animal model.
Methods
Anaesthesia of the rats was achieved as described in chapter 3. Two groups of rats were
studied. In one group, electrophysiological recordings were obtained from one, previously
divided and repaired facial nerve and compared with the other, normal facial nerve in the same
animal (GROUP 1). In another group, the electrophysiological recordings from one facial




Anaesthesia was as described in chapter 3.
Surgery
Surgery was as described in chapter 3, Group 1. These animals were allowed to recover and
kept for three months before electrophysiological assessment.
81
GROUPS 1 & 9
Anaesthesia
Anaesthesia was as described in chapter 3.
Surgery
The animal's fur on both sides of the face was shaved with electric clippers. An area on the
nasal bones below the eyes and an area on the back of the animal were also shaved. Immac
(Reckitt and Colman Ltd, Hull, UK) hair removal cream was applied to the area caudal to the
mouth for about 1 cm2, the shaved area on the nose and the shaved area on the back in order
to produce a smooth surface for optimal electrical contact. The cream was left for 5 minutes
then removed and the animal's skin was washed with chlorhexidine. An incision was made
below the lower border of the mandible and the skin was retracted until the buccal division of
the facial nerve was seen. Surgery was then carried out using an operating microscope (Wild,
Heerbrugg M690) with stepless variable magnification of 3.5 to 18 times. The buccal division
of the left facial nerve was dissected free of associated fascial tissue. This division was
dissected in a proximal direction to the jugular vein, which was coagulated using bipolar
diathermy, taking care to avoid current spread to the nerve. The furcation of the nerve was
identified and the main trunk of the nerve exposed to the stylomastoid foramen. At the
stylomastoid foramen the nerve trunk was transected with microscissors. All other branches of
the facial nerve, except the buccal branch were exposed and transected close to the furcation.
This left the buccal division of the facial nerve solely in continuity with the main trunk. The
main trunk of the nerve was stimulated by a non-traumatic, bipolar, platinum wire electrode
(figure 8.1) and stimulation and recording were performed using a Medelec Sapphire 4ME
EMG recorder (Medelec, Old Woking, UK).
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Figure 8 .1. The divided trunk of the facial nerve in the rat being stimulated by a
bipolar electrode.
Stimulation caused contraction of the small muscles of nose and upper lip. A 6 mm silver /
silver chloride disc recording electrode (Medelec, Old Woking, UK) (the cathode) was placed
just caudal to the angle of the mouth and the non-vibrissae-bearing skin. A second 6 mm silver
/ silver chloride electrode (the anode) was placed over the nasal bones in the midline. A ground
electrode was placed over the back of the animal. A small amount of electrode cream was
placed on each of the three electrodes to improve electrode adhesion and electrical contact.
Placement of the cathode at this site gave the maximal amplitude for recording of the m-wave.
A square wave of 50 ps duration of supra-maximal current intensity (130% ofmaximum) was
then delivered to the facial nerve. This was repeated to give 10 m-wave recordings, which
were digitally filtered (3 Hz low frequency filter, 10 kHz high frequency filter and sweep
speed of 20 ms per division) and amplified before being displayed on the EMG recorder's
screen. One such trace is shown in figure 8.2.
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Figure 8 .2. The m-wave recorded from the facial muscles in the rat from stimulation of the
buccal division of the nerve.
The EMG recorder produced four variables:
1. latency to the start of the m-wave.
2. latency to the peak of the m-wave, where there was two or more peaks present in the
negative phase of the m-wave the latency to the largest peak was recorded.
3. maximum amplitude of the m-wave, where there was two or more peaks present in the
negative phase of the m-wave the amplitude was taken as the distance from baseline to the
largest peak.
4. area under the upward (negative) part of the m-wave.
These variables are shown in figure 8.3.
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Figure 8.3. The variables from the m-wave, recorded in the rat.
Because there is no 'gold standard' to compare the results obtained on electrophysiological
testing, it is necessary to compare one side with the other. It is assumed that these
electrophysiological values are very similar, as it is assumed in clinical testing in the human. If
these results are similar it suggests that the method of testing is accurate. The results were
subjected to the Kolmogorov-Smiranov test for normality, to show that the data was normally
distributed. The parametric t-test for dependant samples was then used to identify differences
between groups. To decide if there was agreement between right and left sides of the same
animal, these data were subjected to a Bland and Altman plot (Bland & Altman 1986). Data
such as this are often analysed inappropriately by correlation coefficients (Bland & Altman
1986). The Bland and Altman plot was developed to compare two different methods of
measuring the same variable, however is applicable, as in this case, to the measurement of
variables from both right and left sides from one animal. This statistical technique is based on
the graphical presentation of data and simple calculations.
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Results
The latencies to the m-wave and latencies to the peak of the m-wave, including the standard
error of the means, in each animal in group 9, are shown in table 8.1. Table 8.2 shows the
amplitude of the m-wave and area under the negative peak ofm-wave, including the standard
error of the means, in each animal.












1 1.678 ±0.009 1.722 ±0.005 3.650 ± 0.004 3.664 ± 0.005
2 1.758 ±0.013 1.644 ±0.015 4.038 ±0.019 3.944 ± 0.025
3 1.324 ±0.005 1.362 ±0.008 2.340 ± 0.148 3.550 ±0.006
4 1.670 ±0.007 1.668 ±0.003 2.336 ± 0.007 2.890 ±0.007
5 1.624 ±0.005 1.682 ±0.004 3.912 ±0.009 4.290 ± 0.004
6 1.512 ±0.005 1.544 ±0.009 2.600 ± 0.006 2.560 ± 0.009
7 1.828 ±0.003 1.762 ±0.008 2.470 ± 0.003 2.778 ± 0.028
8 2.280 ± 0.003 2.130 ±0.004 4.336 ±0.008 4.650 ±0.011
9 1.510 ± 0.015 1.608 ±0.005 2.196 ±0.007 2.792 ± 0.005
10 1.824 ±0.012 1.828 ±0.031 3.774 ±0.008 4.308 ±0.017
11 1.695 ±0.012 1.735 ±0.019 4.110 ±0.039 3.417 ±0.059
12 1.600 ±0.000 1.733 ±0.033 3.463 ± 0.246 3.573 ±0.123
Table 8.1. The average latencies to the m-wave and the average latencies to peak of the m-
wave (with standard error of the mean (SEM)) of the buccal branch of the facial nerve in 12
rats (group 9).







area (pVs) ± SEM
Mean right m-wave
area (pVs) ± SEM
1 2.148 ±0.028 1.746 ±0.008 3.339 ±0.035 2.926 ±0.010
2 3.242 ±0.015 1.333 ±0.013 4.760 ± 0.033 2.334 ±0.024
3 1.804 ±0.016 1.373 ±0.005 3.098 ±0.015 2.540 ±0.012
4 0.917 ±0.005 1.224 ±0.029 1.681 ±0.023 2.396 ± 0.033
5 3.159 ±0.008 3.374 ±0.030 4.315 ±0.009 5.551 ±0.045
6 2.064 ± 0.005 2.449 ± 0.048 2.556 ±0.009 2.320 ±0.054
7 1.839 ±0.011 1.878 ±0.006 3.372 ±0.011 3.650 ±0.013
8 2.278 ±0.013 3.125 ±0.057 3.557 ±0.014 5.825 ±0.115
9 1.148 ± 0.013 0.964 ± 0.007 1.847 ±0.025 1.882 ±0.006
10 1.966 ±0.010 2.128 ±0.018 2.392 ±0.011 3.534 ±0.019
11 2.258 ±0.132 5.381 ±0.273 3.954 ±0.222 7.451 ±0.186
12 2.867 ±0.128 4.253 ± 0.480 5.107 ±0.205 5.657 ±0.708
Table 8.2. The average amplitude of the m-wave and the average area under the negative peak
ofm-wave (with standard error of the mean (SEM)) of the buccal branch of the facial nerve in
12 rats (group 9).
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The Kolmogorov-Smiranov test for normality was carried out on each of the four
electrophysiological variables for the animals in group 9. One such test is shown in figure 8.4.
Figure 8.4 M-wave amplitude, R & L sides in normal rat facial nerves
Kolmogorov-Smirnov d = 0.130, p = n.s.
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The data in all four variable groups was normally distributed. Table 8.3 shows the results of t-
tests for dependant variables carried out on each of the four electrophysiological variables









Left m-wave latency (ms)
Right m-wave latency (ms)
1.692 0.234 12 -0.401 11 0.696
1.702 0.181
Left peak latency (ms)
Right peak latency (ms)








3.331 1.090 12 -1.180 11 0.263
3.839 1.818
Table 8.3. t-tests for dependant variables carried out on each of the four electrophysiological
variables between left and right sides (group 9).
There was no significant difference between the electrophysiological tests of the right and left
nerves using a t-test for dependant variables. This does not, however, mean that there is good
agreement.
The product-moment correlation coefficient (r) between the left and right m-wave latencies is
0.95 (figure 8.5). However, the correlation coefficient measures the relation between the two
sides and not the agreement. Data which are in poor agreement may show high correlation
coefficients.
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Fig 8.5 Correlation of left and right m-wave latencies (Group 9)
Correlation: r= 0.952
Left m-wave latency / (ms)
Figures 8.6 - 8.9 show this data subjected to Bland and Altman plots. Here the zero line on the
y axis indicates zero difference between the two sides. If the differences are normally
distributed (which they are) 95% of these differences will lie within, 1.96 multiplied by the
standard deviation, on either side of the mean difference. These are the 'limits of agreement'.
Provided that differences within ± two standard deviations are not clinically important we can
conclude that the measurements from right and left facial nerves are accurate enough to be
used to assess nerve function.
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Figure 8.7. Bland & Altman plot in normal rat facial nerves (Group 9)
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+ 1.96 x s.d.
1.96 x s.d.
1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5
average m-wave area / (uVs)
6.0
These 'limits of agreement', in other words, where 95% of electrophysiologically measured
differences (95% confidence intervals) would lie are shown in table 8.4.
91
Electrophysiological variable Limits of agreement
m-wave latency 0.162 ms
peak latency 0.916 ms
amplitude ofm-wave 2.341 mV
area ofm-wave 2.921 pVs
Table 8.4 Limits of agreement or 95% confidence intervals for the four electrophysiological
tests.
It can be seen that the confidence intervals for the measured value of m-wave latency is
±0.162 ms. It is not known ifmeasuring the m-wave latency to within ±0.162 ms is accurate
enough to be used to detect differences between normal and repaired nerves. To determine
this, it is necessary to compare these results in normal nerves to results in repaired nerves.
The latencies to the m-wave and latencies to the peak of the m-wave, including the standard
error of the means, in each animal in group 1, are shown in table 8.5. Table 8.6 shows the
amplitude of the m-wave and area under the negative peak ofm-wave, including the standard
error of the means, in each animal.












1 2.916 ±0.050 1.756 ±0.018 5.576 ±0.126 5.236 ±0.032
2 1.902 ±0.007 1.574 ±0.017 2.434 ± 0.004 4.858 ±0.016
3 2.038 ±0.013 1.650 ±0.003 5.054 ±0.012 4.322 ±0.010
4 2.674 ± 0.034 1.956 ±0.014 4.962 ± 0.076 3.672 ±0.179
5 1.890 ±0.018 1.650 ± 0.013 5.026 ± 0.020 4.082 ±0.009
6 1.768 ±0.014 1.506 ±0.018 4.198 ±0.024 3.328 ±0.016
Table 8.5. The average latencies to the m-wave and the average latencies to peak of the m-
wave (with standard error of the mean (SEM)) of the buccal branch of the facial nerve in 6
rats where the left nerve had been repaired 3 months before assessment (group 1).
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area (pVs) ± SEM
Mean right m-wave
area (pVs) ± SEM
1 0.184 ±0.010 1.008 ±0.010 0.849 ±0.014 4.347 ± 0.024
2 0.108 ±0.001 1.229 ±0.016 0.082 ±0.001 5.411 ±0.020
3 0.203 ± 0.002 0.730 ± 0.004 0.520 ± 0.006 1.657 ±0.009
4 0.083 ±0.010 1.967 ±0.051 0.109 ±0.007 2.931 ±0.036
5 0.281 ±0.015 2.230 ±0.016 0.563 ± 0.045 3.825 ±0.019
6 0.447 ± 0.005 2.437 ±0.012 0.868 ± 0.007 4.041 ±0.024
Table 8.6. The average amp itude of the m-wave and the average area under the negative peak
ofm-wave (with standard error of the mean (SEM)) of the buccal branch of the facial nerve in
6 rats where the left nerve had been repair 3 months before assessment (group 1).
The Kolmogorov-Smirnov test for normality was carried out on each of the four
electrophysiological variables in group 1. One such test is shown in figure 8.10. The data in
all four variable groups was normally distributed.
Figure 8.10 M-wave latency, R & L sides (R normal, L repaired) (Group 1)
Kolmogorov-Smirnov d = 0.131, p = n.s.
1.300 1.514 1.729 1.943 2.157 2.371 2.586 2.800
1.407 1.621 1.836 2.050 2.264 2.479 2.693 Expected
latency / (ms)
Table 8.7 shows the results of t-tests for dependant variables carried out on each of the four









Left m-wave latency (ms) 2.078 0.327 6 5.552 5 0.003
Right m-wave latency (ms) 1.682 0.158
Left peak latency (ms) 4.542 1.123 6 0.524 5 0.623
Right peak latency (ms) 4.250 0.715
Left amplitude (mV) 0.218 0.133 6 -5.284 5 0.003
Right amplitude (mV) 1.600 0.704
Left area (pVs) 0.498 0.343 6 -5.842 5 0.002
Right area (pVs) 3.702 1.284
Table 8.7. t-tests for dependant variables carried out on each of the four electrophysiological
variables between left and right sides (group 1).
There is a significant difference between the variables: m-wave latency, m-wave amplitude
and m-wave area. No significant difference was found between the normal and repaired peak
latency. Bland and Altman plots were carried out on the electrophysiological data obtained
from the animals in group 1 (figures 8.11 - 8.14).
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Figure 8.12 Bland & Altman plot in repaired rat facial nerves (Group 1)
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Figure 8.13 Bland & Altman plot in repaired rat facial nerves (Group 1)
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Figure 8.14 Bland & Altman plot in repaired rat facial nerves (Group 1)
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This shows that all the differences between the m-wave latency in the repaired nerves and
normal nerves (group 1) were out with the Timits of agreement' for normal nerves (group 9).
All but one measurement of the difference between m-wave area in the repaired nerves and
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normal nerves (group 1) were out with the 'limits of agreement' for normal nerves (group 9).
The difference in both, the measured amplitude and peak latency, between the normal and
repaired nerves (group 1) were within the limits of agreement for normal nerves (group 9).
Conclusion
Modern electrophysiology recorders can record the muscle action potential produced by
stimulation of the rat facial nerve. Values of m-wave latency and area of the m-wave are
repeatable and reliable and show close agreement between right and left side of the same
animal. Values of m-wave latency and area of the m-wave are measurably different between
normal and repaired facial nerves in the rat. The m-wave latency in the repaired nerve is
longer than in the normal nerve and the area of the m-wave in the repaired nerve is smaller
than in the normal nerve. These two variables (m-wave latency and m-wave area) were used to
assess outcomes of nerve repair.
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Results were obtained from 3 groups of rats, each with six rats per group. Table 9.1 shows
the procedure carried out on the first group of rats studied.
Group no. Number of rats Procedure Time to assessment
1 6 N-N suture 3 months
2 6 N-N defect (4 mm glass tube) 3 months
3 6 N-N defect (4 mm glass tube,
with lOpgBDNF)
3 months
4 6 N-N defect (4 mm glass tube,
with lOpgCNTF)
3 months
5 6 N-N defect (4 mm glass tube,
with 10 pg GDNF)
3 months
6 6 N-N defect (4 mm glass tube,
with 10 pg NT 4)
3 months
7 6 N-N suture (10 pg BDNF and 10
pg CNTF to repair site)
3 months
8 6 N-N suture (10 pg GDNF and 10
pg NT4/5 to repair site)
3 months
Table 9.1. Procedure carried out on the first set of rats studied.
In groups 2-6 above the glass tubes caused a severe fibrous reaction shown in figure 9.1. In
the majority of animals, a neuroma at the proximal end of the buccal division of the facial
nerve was found at re-operation and no electrophysiological data could be obtained. No
meaningful data was therefore obtained from this first set of experiments.
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Figure 9.1. Severe fibrous reaction to the glass tube in the face of the rat.
It was decided that the glass tube reaction was inconsistent with regeneration of the nerve in
the rat facial nerve. It was therefore decided to abandon the use of biodegradable glass tubes
in experiments on the rat facial nerve and a further set of experiments was devised using a
suture repair of the nerve and delivery of neurotrophic factors by an osmotic pump to the
distal limb of the repair site (groups 7 and 8).
Table 9.2 shows the results obtained from the morphological and electrophysiological
variables measured or calculated. All animals in these groups survived the initial surgical
procedure and were able to be assessed after three months. Electrophysiological variables
were obtained form all animals except the second animal in group 7. No recordings could be













ratio M-wave area ratio
1 2.285 1.701 3.144 0.722 0.534 1.251 0.195
1 1.547 1.011 2.158 0.574 0.448 1.208 0.015
1 1.983 0.994 2.113 0.559 0.459 1.235 0.314
1 1.963 1.195 2.121 0.463 0.546 1.367 0.037
1 2.046 1.364 2.349 0.492 0.565 1.145 0.147
1 2.018 1.261 2.284 0.511 0.532 1.174 0.215
7 2.495 2.441 4.005 0.782 0.596 1.152 0.246
7 2.545 1.098 1.977 0.440 0.539 0.000* 0.000*
7 3.443 0.980 1.884 0.452 0.510 1.263 0.054
7 2.440 1.367 2.426 0.529 0.546 1.027 0.159
7 3.939 1.220 2.231 0.506 0.534 1.244 0.091
7 3.329 1.756 2.856 0.550 0.594 1.868 0.177
8 2.330 1.091 1.959 0.434 0.539 1.327 0.327
8 1.229 1.449 2.839 0.695 0.495 1.152 0.719
8 1.980 1.087 2.112 0.513 0.500 1.099 0.078
8 1.306 1.841 2.936 0.548 0.605 1.269 0.055
8 0.743 1.397 2.385 0.494 0.563 1.669 0.157
8 3.144 2.287 3.545 0.629 0.619 1.466 0.262
Table 9.2 Results obtained from the morphological and electrophysiological variables (* no
electrophysiological recordings obtained)
To detect out-liers, half normal plots were constructed of all morphological and
electrophysiological variables in table 8.1. An example of one of these plots is shown in figure
9.2. A 95% confidence line was plotted on the graph (shown as an ellipse) and outliers were
taken as points out with this line.
Figure 9.2 Half-Normal Plot. Variable: Fibre ratio
Observed Value
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Outliers identified by half normal plots were removed from further statistical analysis. Table
9.3 shows the results obtained from the morphological and electrophysiological variables














ratio M-wave area ratio
1 2.285 1.701 3.144 0.722 0.534 1.251 0.195
1 1.547 1.011 2.158 0.574 0.448* 1.208 0.015
1 1.983 0.994 2.113 0.559 0.459 1.235 0.314
1 1.963 1.195 2.121 0.463 0.546 1.367 0.037
1 2.046 1.364 2.349 0.492 0.565 1.145 0.147
1 2.018 1.261 2.284 0.511 0.532 1.174 0.215
7 2.495 2.441 4.005* 0.782 0.596 1,152 0.246
7 2.545 1.098 1.977 0.440 0.539 0.000 0.000
7 3.443 0.980 1.884 0.452 0.510 1.263 0.054
7 2.440 1.367 2.426 0.529 0.546 1.027 0.159
7 3.939 1.220 2.231 0.506 0.534 1.244 0.091
7 3.329 1.756 2.856 0.550 0.594 1.868 0.177
8 2.330 1.091 1.959 0.434 0.539 1.327 0.327
8 1.229 1.449 2.839 0.695 0.495 1.152 0.719*
8 1.980 1.087 2.112 0.513 0.500 1.099 0.078
8 1.306 1.841 2.936 0.548 0.605 1.269 0.055
8 0.743* 1.397 2.385 0.494 0.563 1.669 0.157
8 3.144 2.287* 3.545 0.629 0.619* 1.466 0.262
Table 9.3 Results obtained from the morphological and electrophysiological variables with
out-liers marked (*).
Kolmogorov-Smirnov plots were constructed of all morphological and electrophysiological
variables in table 9.3, excluding out-liers. An example of one of these plots is shown in figure
9.3.
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Fig 9.3 Variable: Fibre ratio
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For all variables, the Kolmogorov-Smirnov value was not significant and therefore the data
could be regarded as normally distributed, as shown in table 9.4.
Variable Kolmogorov-Smirnov value p value
Fibre ratio 0.119 n.s.
Axon diameter 0.184 n.s.
Fibre diameter 0.191 n.s.
Myelin thickness 0.179 n.s.
G-ratio 0.067 n.s.
M-wave latency 0.221 n.s.
Area ofm-wave 0.134 n.s.
Table 9.4 Kolmogorov-Smirnov values for morphological and electrophysiological variables.
Table 9.5 shows the mean results obtained in morphological and electrophysiological variables














ratio M-wave area ratio
1 1.974 1.254 2.362 0.554 0.527 1.230 0.154
7 3.032 1.477 2.275 0.543 0.553 1.092 0.121
8 1.998 1.373 2.629 0.552 0.540 1.330 0.176
Table 9.5 Mean results obtained from the morphological and electrophysiological variables
excluding outlier in table 9.3.
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An F test was carried out on all variables, excluding outliers. This is shown in table 9.6. The
only significant difference between groups was with fibre diameter ratio, t tests were therefore
carried out on the fibre ratio results in the three groups. This is shown in table 9.7. t testing of
each group in respect to the variable of fibre diameter ratio yielded a significantly different
result between groups 1 and 7 and groups 7 and 8. No difference was detected between groups













Fibre ratio 4.260 2 2.130 4.737 14 0.338 6.296 0.011*
Axon
diameter (^m) 0.149 2 0.075 2.205 14 0.157 0.474 0.632
Fibre
diameter (nm) 0.387 2 0.193 3.137 14 0.224 0.863 0.443
Myelin
thickness
(am) 0.002 2 0.001 0.663 15 0.044 0.018 0.983
G-ratio 0.002 2 0.001 0.021 13 0.002 0.569 0.579
M-wave
latency ratio 0.171 2 0.086 2.108 15 0.141 0.609 0.557
M-wave area
ratio 0.008 2 0.004 0.159 14 0.011 0.364 0.702
Table 9.6. F test ofmorphological and electrophysiological variables (*significant)
Group 1 group 7 group 8




group 7 - - t=2.428
p=0.04
group 8 - - -
Table 9.7 t tests for the fibre ratio of each group.
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There were therefore statistically significant differences in the number of fibres between
groups 1 and 7 and groups 7 and 8. There was no other difference in any of the other
parameters measured.
Discussion
The use of biodegradable glass for facial nerve repair by entubulation resulted in unexpected
fibrosis at the site of operation. Many studies have shown the safety ofCRG for nerve repair,
but these studies have not involved the rat facial nerve. In small animals such as the rat, it is
presumed that the tube is proportionally larger in size and volume of glass, resulting in slower
breakdown and degradation. When this mass of CRG was inserted under the skin of the face
of the rat it may have been that other factors existed which were unique to this site and caused
fibrosis. It was not possible to manufacture glass tubes with a smaller wall thickness, which
may have prevented at least some of the reactions seen in these experiments. Any benefit
which may have arisen from nerve entubulation was overcome by the reaction to the glass and
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the use of CRG in the rat had to be abandoned. Studies have used neurotrophic factors
delivered to the site of nerve repair without nerve entubulation to some effect (Newman et al
1996). In the present study, neurotrophic factors were delivered just distal to the repair site
with an ultra-fine needle inserted into the nerve sheath.
The 'trophic' actions of neurotrophic factors are well known. These actions include gene
activation for cell growth and differentiation, neurite outgrowth, protein synthesis, alteration
in membrane permeability and cytoskeletal rearrangement. But neurotrophic factors may also
have a 'tropic' action where some guidance of the direction of growth occurs down a chemical
gradient resulting in chemo-attraction of the growing proximal nerve stump. Thus, some
authors have suggested this 'neurotropic' effect is responsible for selective regeneration into a
distal nerve branch after neurotmesis (Maki et al. 1996).
If neurotrophic factors are truly 'trophic' delivery of these growth factors in this experiment
may have stimulated growth and result in improved regeneration of the nerve. If neurotrophic
factors are also 'tropic' then this delivery may guide regenerating axons down the distal nerve.
There are thus two potential types of benefits for the use of neurotrophic factors when
delivered in the method described in this experiment. The increase in fibre numbers may have
resulted from increased sprouting from the nerve growth cone, induced by the combination of
BDNF and CNTF, therefore producing more fibres in the distal nerve. A second possibility is
that the tropic action of these growth factors caused a greater proportion of neurites (which
were not increased in number), to enter the distal stump of the nerve.
This study shows that the local delivery of neurotrophic factors is technically feasible and
does not result in side effects to the animal.
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The finding that a combination of CNTF and BDNF increases the number of fibres in the
regenerated facial nerve is an exciting discovery. It suggests that the regeneration of peripheral
nerves can be influenced by exogenous chemicals. It has been known for many years that the
number of fibres increases after nerve repair. This increase is presumably due to increased
sprouting of neurites at the growth cone of the neurone or due to inhibition of apoptosis in
neurites which do not reach their target organ.
The fate of regenerated nerve fibres has been described for decades. It has been shown that the
size of fibres after repair, although partly influenced by the parent fibres is mainly dependant
on factors peripheral to the point of injury (Hammond & Hinsey 1945; Simpson & Young
1945). Contact with the end organ is of paramount importance in achieving large diameter
fibres (Sanders & Young 1945; Weiss et al 1945). In an elegant study, Aitken et al carried
out various experiments on a motor nerve in the rabbit, the nerve to the medial head of
gastrocnemius, which contains approximately 400 myelinated axons (Aitken et al 1947).
When this nerve was left without a peripheral connection, by crushing it proximally and
cutting it distally, turning the stump aside and fixing it to fascia, it formed a neuroma. The
number of fibres was very much more in the nerve which formed a neuroma than in an
equivalent nerve which had undergone transection and repair. The number of fibres in a
regenerated nerve is therefore not a good indicator of success after nerve repair. Some studies
have not appeared to accept this and have used the number of nerve fibres after repair to
suggest a potential improvement in nerve regeneration. (Aebischer et al. 1987; Santos et al.
1998). The idea that, because there are more nerve fibres after regeneration, there will be a
functional improvement is somewhat naive, and may be contrary to what occurs in reality.
Indeed, some authors suggest that the reduction in the number of nerve fibres to normal, or
near normal values after nerve injury is an indicator of a good outcome (Aitken et al 1947).
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The fibres identified and counted in this study, therefore (which were all identified by a myelin
sheath and therefore myelinated) had not necessarily reached an end organ. Aitken et al
demonstrated regeneration in a motor nerve co-apted to a cutaneous nerve, suggesting that
motor fibres can be misdirected to supply non-muscular end-organs (Aitken et al 1947).
Despite the various morphological and electrophysiological measures used in this study, only
fibre number was significantly affected by the use of neurotrophic factors. No other variable
reached statistical significance and there appeared to be no trend for benefit in the growth
factor treated group, which may have suggested a difference had there been larger numbers of
animals in the groups.
In this study, while an increased number of nerve fibres where obtained with one group of
neurotrophic factors, the end point of regeneration is not known. It is possible that after three
months (when these experiments were assessed) 'die-back' of fibres which had not reached an
end-organ may have resulted in an eventual return of fibre numbers to the level of the other
two groups.
The time of assessment of the nerve repair is important in any experiment which involves the
use of neurotrophic factors. If neurotrophic factors increase the number of regenerating fibres
initially, but not the final number of fibres in the nerve no useful effect will be obtained. The
ideal time to assess the effect of any treatment on nerve repair is when the number of fibres
fails to increase or decrease after the initial neurotmesis. This could be achieved by having
many groups of experiments (such as carried out above) and assessing the facial nerve at
various time intervals (e.g. 30, 60, 90, 120, 150, 180 days). This would be a large undertaking
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and if neurotrophic factors were used this would prove very expensive. It was decided
therefore in this study to assess the rat nerve at 90 days only and other authors have used this
time interval (Aebischer et al 1987; Newman et al 1996; Santos et al 1998). Although there
may have been further changes after this time, the present work was a comparison of nerve
repair with and without neurotrophic factors, assessed at the same time interval. It has also
been shown that in the rat, where the facial nerve is divided at the stylomastoid foramen, there
is recovery of function (as seen by movement of the vibrissae) as early as 17 days after
neurotmesis and surgical repair (Kohmura et al. 1999). This would suggest that 90 days is
certainly sufficient time for re-growth of axons to occur from the buccal division of the nerve
and time to allow at least some maturation of these fibres. In the human, improvement of
facial nerve grading can occur even two years after repair of a nerve injury (Malik et al.
2001). As the osmotic pump used in this study delivered its contents over two weeks, then at
the very least, the fastest growing axons would have been supplied with neurotrophic factors
during their re-growth.
Abandoning the use of CRG tubes for nerve repair in the rat allowed concentration on the
effect of the two sets of neurotrophic factors (BDNF and CNTF, and NT4/5 and GDNF). Due
to time and financial constraints of the study, it was not possible to examine the effect of four
groups which would have shown which of the factors, BDNF or CNTF was responsible for
the increase in numbers of regenerated nerve fibres (assuming that this effect is not due to
synergism between the neurotrophic factors).
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Conclusion
The null hypothesis, 'neurotrophic factors have no influence on regeneration of the facial
nerve after division and repaircannot be rejected in these experiments in the rat.
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Results were obtained from 3 groups of sheep. Table 10.1 shows the procedure carried out on
each group.
Group Number of sheep Procedure Time to assessment
1 6 N-N suture 9 months
2 5 N-N suture with entubulation
and saline pump
9 months
3 6 N-N suture with entubulation
and neurotrophic pump
9 months
Table 10.1. Procedure carried out on each group of sheep, N-N = Nerve-to-nerve
In these groups, the glass tubes did not cause a severe fibrous reaction and no animal
developed an abscess or required removal of the tube. Neuromas were not identified at re¬
operation. Tables 10.2 and 10.3 shows the results obtained from the morphological and
electrophysiological variables measured or calculated.
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1 49.10 17.50 31.60 0.76 3.24 3.15
1 63.50 13.60 49.90 2.88 6.33 2.14
1 23.20 20.70 2.50 1.22 3.80 3.41
1 38.00 8.60 29.40 0.82 3.54 1.41
1 46.90 8.43 38.47 0.70 3.66 2.89
1 47.50 11.70 35.80 0.60 7.26 1.07
2 35.50 20.68 14.82 1.65 4.85 3.86
2 42.30 35.28 7.02 0.74 5.00 4.36
2 49.60 35.71 13.89 1.28 4.82 3.08
2 44.30 30.71 13.59 0.72 7.53 2.94
3 63.50 15.40 48.10 1.18 3.46 3.71
3 47.60 8.00 39.60 0.92 3.14 0.17
3 54.00 12.90 41.10 1.34 5.72 2.79
3 32.10 17.70 14.40 0.96 8.10 4.88
3 40.70 17.10 23.60 0.54 3.38 2.44
Table 10.2 Results o itained of electrophysio ogical measurements.
Mean Jitter Fibre Myelin
frs) Axon diameter (um) Diameter (um) Thickness (um) g-ratio
1 13.00 Failure oftissue processing
1 14.00 2.06 4.43 1.19 0.46
1 10.00 1.92 3.78 0.93 0.49
1 10.00 2.46 4.40 0.97 0.54
1 18.00 2.40 4.75 1.17 0.49
1 9.00 2.44 3.97 0.77 0.59
2 Unavailable for 1.44 3.03 0.80 0.45
2 technical 2.46 4.96 1.25 0.46
2 reasons 2.50 4.34 0.92 0.54
2 1.41 2.56 0.57 0.54
3 14.00 2.01 3.41 0.70 0.58
3 19.00 2.26 3.74 0.74 0.57
3 17.00 Failure oftissue processing
3 14.00 1.45 2.46 0.50 0.58
3 27.00 2.23 3.68 0.72 0.57
Table 10.3 Results obtained from the morphological and electrophysiological variables.
In group 2, no measurements of jitter were obtained due a fault with the electrophysiology
equipment. This had the effect that there was no placebo limb for these experiments involving
the measurement of jitter. It was still possible however, to compare the measurements ofjitter
in group 1 and in group 3.
In one animal in group 1 and in one animal in group 3 the process of tissue processing of the
nerve failed and no histology was obtained for these animals. These histological results were
excluded from the analysis although the electrophysiological results were analysed for these
two animals.
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To detect out-liers, half normal plots were constructed of all morphological and
electrophysiological variables in tables 10.2 and 10.3. A 95% confidence line was plotted on
the graph and outliers were taken as points out with this line.
Outliers identified by half normal plots were removed from further statistical analysis. Tables
10.4 and 10.5 show the results obtained from the morphological and electrophysiological
variables measured or calculated with outliers marked (*).
Maximum Minimum
conduction conduction Absolute Relative
velocity velocity CV-range refractory period Refractory
Group (ms1) (ms1) (ms1) (ms) period (ms) Amplitude (mV)
1 49.10 17.50 31.60 0.76 3.24 3.15
1 63.50 13.60 49.90 2.88* 6.33 2.14
1 23.20 20.70 2.50 1.22 3.80 3.41
1 38.00 8.60 29.40 0.82 3.54 1.41
I 46.90 8.43 38.47 0.70 3.66 2.89
1 47.50 11.70 35.80 0.60 7.26 1.07
2 35.50 20.68 14.82 1.65 4.85 3.86
2 42.30 35.28 7.02 0.74 5.00 4.36
2 49.60 35.71 13.89 1.28 4.82 3.08
2 44.30 30.71 13.59 0.72 7.53 2.94
3 63.50 15.40 48.10 1.18 3.46 3.71
3 47.60 8.00 39.60 0.92 3.14 0.17
3 54.00 12.90 41.10 1.34 5.72 2.79
3 32.10 17.70 14.40 0.96 8.10 4.88
3 40.70 17.10 23.60 0.54 3.38 2.44
Table 10.4 Results obtained from t ie electrophysio ogical variables with outliers marked (*).
Axon diameter Fibre Myelin
Group Mean Jitter (ps) (pm) Diameter (pm) Thickness (pm) g-ratio
1 13.00 Failure oftissue processing
1 14.00 2.06 4.43 1.19 0.46
1 10.00 1.92 3.78 0.93 0.49
1 10.00 2.46 4.40 0.97 0.54
1 18.00 2.40 4.75 1.17 0.49
1 9.00 2.44 3.97 0.77 0.59
2 Unavailable for 1.44 3.03 0.80 0.45
2 technical 2.46 4.96 1.25 0.46
2 reasons 2.50 4.34 0.92 0.54
2 1.41 2.56 0.57 0.54
3 14.00 2.01 3.41 0.70 0.58
3 19.00 2.26 3.74 0.74 0.57
3 17.00 Failure of tissue processing
3 14.00 1.45 2.46 0.50 0.58
3 27.00 2.23 3.68 0.72 0.57
Table 10.5 Results obtained from the morp lological and electrophysiologica variables with
outliers marked (*).
Kolmogorov-Smirnov plots were constructed of all morphological and electrophysiological
variables in tables 10.4 and 10.5, excluding outliers. For all variables, the Kolmogorov-
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Smirnov value was not significant (tablet0.6) and therefore the data was assumed to be
normally distributed.
Variable Kolmogorov-Smirnov value p value
Axon diameter 0.149 n.s.
Fibre diameter 0.091 n.s.
Myelin thickness 0.146 n.s.
G-ratio 0.209 n.s.
Max conduction velocity 0.128 n.s.
Min conduction velocity 0.178 n.s.
CV range 0.184 n.s.
Absolute refractory period 0.164 n.s.
Relative refractory period 0.173 n.s.
Amplitude 0.065 n.s.
Jitter 0.213 n.s.
Table 10.6 Kolmogorov-Smirnov values for morphological and electrophysiological variables.
An F test was carried out on all variables, excluding outliers. This is shown in table 10.7. The
only significant difference between groups was with minimum conduction velocity. T tests
were therefore carried out on the minimum conduction velocity in the three groups. This is
shown in table 10.8. T testing of each group in respect to the variable of minimum conduction
velocity yielded a significant result between groups 1 and 2 and groups 2 and 3. No difference
















velocity (ms"1) 50.522 2 25.261 1576.216 12 131.351 0.192 0.828
Minimum
conduction
velocity (ms"1)* 830.667 2 415.333 329.534 12 27.461 15.124 0.001*
Conduction
velocity range
(ms"1) 1172.804 2 586.402 2059.984 12 171.665 3.416 0.067
Absolute
refractory
period (ms) 0.178 2 0.089 1.202 11 0.109 0.812 0.469
Relative
refractory
period (ms) 2.192 2 1.096 38.098 12 3.175 0.345 0.715
Amplitude
(mV) 3.547 2 1.773 18.183 12 1.515 1.170 0.343
Mean jitter (ps) 93.867 1 93.867 172.133 9 19.126 4.908 0.054
Axon diameter
(pm) 0.251 2 0.126 1.785 10 0.178 0.705 0.517
Fibre diameter
(pm) 2.016 2 1.008 5.423 10 0.542 1.859 0.206
Myelin sheath
thickness (pm) 0.255 2 0.128 0.403 10 0.040 3.170 0.086
G-ratio 0.013 2 0.007 0.019 10 0.002 3.504 0.070
Table 10.7. F test ofmorphological and electrophysiological variables (*significant)
Group 1 2 3
1 - t = 4.603 t = 0.292
p = 0.002 p = 0.777
2 - - t = 4.470
p = 0.003
3 - - -
Table 10.8. t tests for t le minimum conduction velocity of each group.
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Discussion
In the sheep, the glass tubes did not seem to cause a severe inflammatory reaction, as was the
case in the rat. This may have been due to the size of the tube compared to the animal. In the
sheep the tube was proportionally of a much smaller volume.
The results obtained in these experiments show that there is no difference in the
electrophysiological variables measured between the neurotrophic factor treated group of
animals and in the nerve suture group. No variable reached statistical significance and there
appeared to be no trend for benefit in the growth factor treated group, which may have
suggested a difference had there been larger numbers of animals in the groups.
The only significant finding in this group was with minimum conduction velocity in the saline
treated group which was higher than in the other two groups of animals (the sutured only
group and the neurotrophic factor treated group). The reason for this difference, if genuine, is
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difficult to explain. Examining the data it is evident that this result is not due to an outlier
(which would have been removed from the analysis by the half-normal plot). There was
however, no corresponding increase in any morphological characteristics in this group, which
could corroborate this finding as genuine, and it is assumed that this result is spurious. This
would suggest that there does not appear to be an advantage of entubulation as a method of
nerve repair. The finding that the placebo group had a higher minimum conduction velocity
than the other two groups does not change the finding that the neurotrophic factor group
showed no such increase in minimum conduction velocity.
Unlike in the rat, the number of fibres in the sheep facial nerve was not counted. There were
two reasons for this. The buccal division of the sheep facial nerve was of a larger diameter
than in the rat nerve. Processing of the tissue was, to some extent, unreliable due its large size
and undoubtedly fibres were 'lost' to microscopic analysis by inadequate fixation in some
nerves. In two animals, tissue processing failed completely and these animals had to be
excluded from morphological analysis. In other nerves the transverse section was so large that
it would have been technically impossible to reassemble an image of the entire nerve to allow
absolute fibre counts to be performed. Furthermore, as discussed in chapter 9, an increase in
the absolute number of fibres does not necessarily suggest functional benefit.
The negative findings of this study in the sheep facial nerve are disappointing. Despite this, it
is a powerful statement concerning neurotrophic factors in a large animal model. Trials in
humans of neurotrophic factors have also proved disappointing and two trials ofCNTF in the
treatment of motor neurone disease have been discontinued because of adverse effects and
failure to slow the progression of the disease (ALS-CNTF treatment study 1993; Longo
1994). With many outcome measures assessed, and none identified as showing benefit, we
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must assume that the neurotrophic factors used here, delivered in this way and concentration
have no effect on nerve recovery. The sheep is a more complex animal than the rat, and more
akin to the human in terms of peripheral nerve repair, hence its use in these and other
experiments on nerve repair. Although some studies of nerve repair using neurotrophic factors
have shown a benefit in rodents none, as yet, have shown measured benefit in a large animal.
This will be a prerequisite for human studies with neurotrophic factors and repair of
peripheral nerves.
Conclusion
The null hypothesis, ''neurotrophic factors have no influence on regeneration of the facial
nerve after division and repair', cannot be rejected in these experiments in the sheep. Also,




A combination of CNTF and BDNF increased the number of fibres in the rat facial nerve but
did not change other morphological measurements. There was no perceived change in
electrophysiological variables. There is some confusion in the literature as to whether an
increase in fibre numbers is a useful indicator of improvement in nerve regeneration and some
would suggest that an increase in fibre numbers is an indicator of poor outcome. The fact that
there can be a dramatic increase in the number of fibres in a nerve which terminates in a
neuroma suggests that fibre numbers is not a good indicator of nerve regeneration. The
measurements of axon diameter, fibre diameter and myelin sheath thickness appear to be
better indicators of recovery of nerve function.
A combination of BDNF, CNTF and GNDF had no effect on the morphology of the sheep
facial nerve after repair. There was no perceived change in electrophysiological variables,
with the exception of minimum conduction velocity in the placebo (saline) group which is
likely to be a spurious result.
It is likely that recovery to normal will never be achieved after transection of the facial nerve,
regardless of what treatment is given, and what advancements are made in nerve research. The
facial muscles are represented by a large area on the motor cortex and control of these
muscles is learned in the early years of life. A considerable problem in regeneration of a
divided facial nerve is that these connections are haphazard and random, and clinically,
synkinesis occurs. It is unlikely that neurotrophic factors will influence how proximal nerve
fibres re-innervate their original muscle motor end plates. One criticism of using neurotrophic
factors in an effort to improve upon current results is that even if nerve regeneration is
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improved upon, synkinesis will be present to the same or even to a greater extent. However
synkinesis can be treated effectively and safely by botulinum toxin injections (Armstrong et al
1996). Furthermore, synkinesis is only a problem when a lesion affects more than one division
of the facial nerve and regeneration occurs. It has also been noted, that after facial nerve
repair, movement is rarely restored to the forehead. There is therefore capacity for increased
innervation to this area. It is also the case that even in the adult, there exists enough neuronal
plasticity for facial muscle movements to be relearned after facial nerve reinnervation
procedures (Sood et al. 2000). If more nerve fibres can be recruited to innervate facial
muscles there is then more scope to improve upon cosmesis with other techniques, some of
which use the selective removal of these unwanted muscle movements. The increase therefore,
in movement of the face, even without fine muscle control is still a goal worth achieving.
Unfortunately, it cannot be said from the present work that that step is any closer to being
achieved.
If animal experiments with neurotrophic factors are to improve upon the functional outcome
of facial nerve repair then it will be necessary to identify neurotrophic factors which influence
the size of fibres innervating the facial musculature and the electrophysiological results after
repair. The present work has established a useful model for facial nerve repair in two species
and has established that neurotrophic factors can be delivered to some effect (on total number
of fibres, in the rat), all-be-it without improvement in function.
The next step, if this research were to be continued would be to evaluate the effects of BDNF
and CNTF alone in two groups of animals.
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The osmotic pump delivery system is easy to use and did not result in problems in either the
rat or the sheep. However an improvement in the delivery of neurotrophic factors could be
achieved by the use of a slow-release biodegradable reservoir and such a method of delivery
has been devised (Kohmura et al 1999).
There may be several explanations as to why there was no functional improvement in nerve
repair in these experiments:
1. The delivery of the neurotrophic factors may have been inadequate
2. The dose may not have been optimal (either too high or too low)
3. The system of delivery may have interfered with functional improvement
4. Neurotrophic factors may have improved nerve regeneration at a level which could
not be detected by the methods used
5. Neurotrophic factors may not have improved the functional outcome of nerve
regeneration
The fact that there was an effect on fibre numbers in the rat facial nerve, suggests that the
delivery system was effective, and that the neurotrophic factors were active when supplied to
the regenerating nerve. It also suggests that these neurotrophic factors were active on the nerve
at the concentrations used, although different concentrations may have caused different effects
on nerve regeneration. It is possible that the delivery system including the catheter and needle,
in the rat, and the catheter and CRG tube in the sheep interfered with improved regeneration.
This does not seem to be the case however, as the animals in the saline control group of sheep
experiments did not have a poorer functional outcome than either the animals in the sutured
group or the neurotrophic factor treated groups. It is also possible that neurotrophic factors
improved regeneration at a level which was too subtle to be detected by the methods used in
these experiments. It is unlikely however, given the array of functional and morphometric tests
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used here, that subtle differences which would be clinically useful exist with the use of
neurotrophic factors. This leaves the depressing probability that exogenously administered
neurotrophic factors do not influence that fate of facial nerve repair.
From its inception this was a very ambitious project. Many studies on the use of neurotrophic
factors are contradictory and much work has concentrated on in vitro experiments which,
although helpful, do not advance the treatment of patients with peripheral nerve injuries. This
work has used many measures of outcome to investigate the effect of neurotrophic factors and
has shown little benefit in the mammalian facial nerve for the use of the most likely candidates
of growth factors. It is unlikely that in the human the delivery of these factors to the site of
nerve repair will improve upon the current level of function to be expected after nerve repair.
The exception to this is in the number of fibres found in the rat facial nerve. This however, did
not appear to result in a better functional result. The number of nerve fibres may not,
ultimately be relevant to the function of the nerve. Indeed it is known that the number of fibres
in the human facial nerve may decrease to approximately 10% of the normal value (Axon &
Ramsden 1999) in chronic conditions without a noticeable effect on the function of the face.
More fibres do not mean more function in the face. It is more likely that the size of the fibres
and myelination are important. These parameters affect the speed of conduction in the nerve.
Furthermore, a nerve fibre which does not communicate with a muscle motor end plate is of
no value to patient or laboratory animal.
The enhancement of peripheral nerve repair is still an elusive goal which will probably require
many more negative studies before positive findings are uncovered.
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Take 3.000 g of 1% p-phenelenediamine powder and dissolve in 300 ml of distilled water,
using a magnetic stirrer, for 10 minutes. P-phenelenediamine is light sensitive and all
glassware used must be cover in aluminium foil to protect it from light. Filter the mixture and
place in slide trays, again covered from the light.
2.5% gluteraldehyde in 0.1M sodium cacodylate buffer
Take 50 ml of 0.2M sodium cacodylate buffer, pH 7.4. Add 10 ml of 25% gluteraldehyde. pH
to 7.4 again. Make up to 100 ml with distilled water.
0.2M sodium cacodylate buffer, pH 7.4
Take 50 ml of 0.4M sodium cacodylate, add 0.2M hydrochloric acid (about 8 ml) to pH the
solution to 7.4. Make up to 100 ml with distilled water.
0.4M sodium cacodylate
Dissolve 8.5612 g sodium cacodylate in 50 ml of distilled water. Make up to 100 ml with
more distilled water.
0.2M hydrochloric acid
Take 20 ml of IN hydrochloric acid and make up to 100 ml, 0.2M hydrochloric acid.
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5% sucrose buffer solution
Take 50 ml of 0.2M sodium cacodylate buffer and using a magnetic stirrer add 5.000 g of
sucrose. pH to 7.4 and make up to 100 ml with distilled water.
0.1. osmium tetroxide in 0.1M sodium cacodylate buffer
Osmium tetroxide is dangerous and must only be handled in a fume cupboard. Take a 0.1 g
ampoule of osmium tetroxide and remove its paper label, cleaning the ampoule with absolute
alcohol to remove all trace of the paper. Place this in a universal bottle, with the cap tightly
screwed closed, and shake to break the ampoule. Add 5 ml of 0.2M sodium cacodylate buffer,
pH 7.4 and 5 ml of distilled water and shake to mix. Place the bottle overnight in the
refrigerator to allow the crystals to dissolve.
Araldite epoxy resin
Araldite causes skin irritations and should be handled in a fume cupboard. There are four
components of the resin which when mixed slowly polymerise:
1. Araldite CY212
2. Dodecenyl succinic anhydrite (hardener)
3. Dibutylphthalate (plasticiser)
4. Benzyldimethylamine (accelerator)
Mix 1 and 2 in equal proportions. Mix 3 and 4 in a 2:1 mix (two measures of dibutylphthalate
with one measure of benzyldimethylamine). Fill a universal bottle to its 'shoulder' with the 1 +
2 mixture and add 0.5 ml of the 3 + 4 mixture. Leave overnight on the rotator and store in the
refrigerator.
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Pyronin B and Toluidine Blue stain
Mix 1 g of di-Sodium tetrahydoborate decahydrate (Borax) in 100 ml of distilled water (1%
solution) with a magnetic stirrer for 1 hour). Then mix 1 g of toluidine blue (C15H16N3SC1)
and again stir for 1 hour (this makes 1% solution of toluidine blue in 1% borax).
Mix 1 g of Pyronin B in 100 ml of distilled water (1% solution, use magnetic stirrer for 1
hour).
Mix four parts of the 1% solution of toluidine blue in 1% borax with one part of the 1%
Pyronin B solution. Filter the combined solution to remove any precipitate.
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Appendix 2
Papers resulting from this work:
Gilchrist T., Glasby M.A., Healy D.M., Kelly G., Lenihan D.V., McDowall K.L., Miller LA.,
Myles L.M., 1998 "In vitro nerve repair - in vivo. The reconstruction of peripheral nerves by
entubulation with biodegradeable glass tubes - a preliminary report". British Journal of
Plastic Surgery vol 51, pp 231 -237.
136
